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ABSTRACT
A Meta-analysis o f  the Alcohol Treatment
Outcome Literature: 1993 to 2000
by
Anthony Phillip Tranchita, Master o f  Science 
Utah State University, 2002
Major Professor: Dr. David Stein
Department: Psychology
Alcohol misuse is a very common problem with high financial and personal costs. 
Treatment requires allocation o f  limited resources for optimal impact. Responsible 
decision making in this area should be based upon reasoned weighing o f  research 
evidence. Miller and colleagues completed a meta-analytic review o f  all controlled 
studies published before 1992 to help clinicians do just that. The coding system they 
employed examined methodological quality, as well as outcome, to obtain a rank­
ordering o f  treatments that seem to have the most quality research support. The current 
study attempts to extend this work utilizing the same coding on studies published since 
1992, and combine both databases o f  articles. Revised rank orderings o f  treatments and 
conclusions regarding variables related to outcomes are reported. Implications are 
discussed, along with limitations o f  this review. An upward trend in methodological 
quality over time was also discovered.
(144 pages)
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INTRODUCTION
Alcohol abuse and dependence adversely affect the work habits, social relations, 
and psychological and physical health o f  those who face these afflictions. Helping 
people achieve effective treatment is an important goal for psychologists and all involved 
in treatment services. Weisner, Greenfield, and Room (1995) found that the number o f  
people with alcohol disorders utilizing treatment services every day rose to 563, 000  in 
the 1980s. As such, it is tremendously important that these people receive the best 
treatment possible. Given limited resources available for treatment, it would seem that 
applying treatments shown by research to be the most cost-effective would be the best 
way o f  accomplishing this goal.
The field o f  alcohol misuse treatment, along with the rest o f  psychological 
treatment, has been moving toward accountability for outcomes. The research literature 
on the effectiveness o f  specific treatments has not only grown in the number o f  studies, 
but has also improved in sophistication and scientific rigor. Methodological advances 
such as standardized diagnostic criteria, thorough description o f  study samples, training 
o f  treatment providers, standardization o f  treatments often by the use o f  manuals, quality 
control checks, and longitudinal assessments have pushed the field o f  alcoholism  
treatment research further along and allowed for investigation o f  more complex issues 
(Carroll, 1997).
However, while certain treatments have been shown to be effective in the
literature, there exists a gap between empirically tested treatments and common practice 
in the United States (Miller et al., 1995). It is imperative that the process o f  applying
scientific rigor to treatment choices and practice be continued and, in the case o f  some 
newer treatments, begun. One way o f  addressing this problem is to summarize the 
outcom e literature in a meaningful way so that is more readily accessible to clinicians. A 
good way to achieve this goal is applying meta-analytical procedures to the outcome
literature.
A search o f  the literature by the present author revealed a number o f  reviews and 
meta-analyses o f  the outcome literature published in the last 10 years. These reviews 
focused specifically on the efficacy o f  alcohol treatments and the cost effectiveness o f  
treatments. However, the available reviews and meta-analyses had their shortcomings. 
Several focused on only one treatment modality such as relapse prevention. While this 
type o f  analysis was helpful, it did not fully synthesize treatment literature at a level 
which aided in treatment decisions across modalities. Meta-analyses that have compared 
treatment modalities are somewhat dated. The most recent comprehensive meta-analysis 
covered articles only up to 1993. DeRubeis and Crits-Christoph (1998) criticized one o f  
the meta-analyses by Holder, Longbaugh, Miller, and Rubonis (1991), which included 
studies through 1990, for the fact that most studies “predate the arrival o f  treatment 
manuals for therapy research” (p. 47). Treatment manuals were used in therapy research 
to ensure the standardization o f  treatment across subjects, and are becoming common in 
outcome research studies. This is one example o f  how the published studies did not 
necessarily reflect current research. Furthermore, an update o f  alcohol treatment 
outcome research is important, as patterns o f  results in research can change over time.
For example, Finney and Monahan (1996) noted that “because o f  the small number o f
2
Jstudies o f  individual treatment modalities, patterns o f  findings across studies can change 
over time as more studies are considered” (p. 241).
For this literature to be optimally accessible to clinicians, it must be continually 
updated to reflect the current trends in the research literature. This study was an attempt 
to update the outcome literature by using meta-analytic procedures on the outcome 
studies completed since 1992. This study should help identify which treatment modalities 
have received the most support from research.
In the section that follows, a brief review o f  the literature published to date is 
presented to orient the reader to themes and apparent outcome trends. Particularly 
emphasized is the meta-analysis by Miller et al. (1995). This study included some 
quantitative procedures for examining the effects o f  treatments across studies. However, 
most importantly, this review will provide an orientation to the reader and help justify the 
premise that an updated meta-analysis based on the methodology used by Miller et al. is
needed.
4REVIEW OF THE LITERATURE
The literature review that follows will be separated into three categories. Studies 
which reviewed or applied meta-analytical procedures to pharmacological treatments for 
alcohol misuse, those which focused on only one nonpharmacological treatment, and 
those which compared multiple modalities. The purpose o f  this section is to review what 
has been done by past investigators to synthesize the alcohol treatment literature and to 
highlight some o f  the findings.
Reviews o f  Pharmacological Treatments
Several studies were located by the present writer that evaluated the use o f  
psychopharmacological treatments for alcohol misuse. While each o f  these articles 
reviewed studies o f  more than one medication, they were included in this section because 
no comparison o f  pharmacological interventions and psychosocial interventions was
conducted.
Batel (1995) reveiwed randomized controlled trials o f  alcohol treatment with 
medications between 1960 and 1993. He found support for the use o f  certain 
medications in the treatment o f  alcoholism, such as citalopram, fluoxetine (Celexa and 
Prozac, both selective seratonin reuptake inhibitors), naltrexone (narcotic antagonist), 
and acamprosate, a gamma-aminobutyric acid (GABA) agonist. On the other hand, 
certain other drugs appeared to be o f  little or no benefit, such as zimeldine, tetrabamate, 
L-Dopa, and viloxazine. It is important to keep in mind that these conclusions were 
based on only two or three published evaluations o f  each o f  the medications.
5A second review by O’Brien and McKay (1998) reviewed the use o f  medication 
for treating several substance use disorders including nicotine, cocaine, opioids, and 
alcohol. Their review o f  medication for treating alcohol misuse included 27 studies on 
the use o f  antidisotropic agents, seratonergic agents, acamprosate, and opioid antagonists. 
They found mixed results for the use o f  antidisotropics (i. e., only 2 o f  7 studies found 
positive results), but noted studies that included behavioral contracting with a significant 
other found better results. The studies in their review found little support for the use o f  
seratonergic agents, with the exception o f  clients with comorbid anxiety disorders 
(Buspirone) or depression (tricyclics). Acamprosate, which seems to act as a GABA  
receptor agonist, was supported by all six studies reviewed. Their review also found 
support for the use o f  opioid antagonists such as naltrexone and nalmefene in the 
treatment o f  alcohol use disorders (3 out o f  5 studies showed lasting positive results).
Swift (1999) reviewed evidence for the use o f  pharmacotherapy for alcohol 
dependence and briefly explained how each o f  the drugs purportedly worked to 
counteract alcohol use and misuse. This study concluded that the empirical evidence 
supported the use o f  opioid antagonists (naltrexone, nalmefene), Acamprosate, and 
dopaminergic-antagonists such as tiapride. However, the author also noted the mixed 
nature o f  the findings for and against the use o f  opioid antagonists, listing a number o f  
studies that did not find a positive effect for naltrexone. Swift also concluded there was 
little support for the use o f  aversion drugs (such as disulfiram and calcium carbimide), 
mood stabilizers (lithium, carbamazepine), sedatives like benzodiazapines, or for 
seratonergic drugs (SSRIs, Buspirone, Ondansetron, and Ritanserin). Further discussion 
was given to the treatment o f alcohol dependence in the presence o f  a comorbid disorder
such as depression, anxiety, or schizophrenia. While Swift (1999) included fewer studies 
in his review than his contemporaries, he concluded that treating the comorbid disorder 
with medication was indicated, and would in turn have some effect on alcohol
consumption.
This conclusion was also reached by Litten and Allen (1995) and Malec, Malec 
and Dongier (1996). Litten and Allen reviewed the literature and found support for the 
use o f  tricyclic antidepressants and seratonin reuptake inhibitors for the treatment o f  
depressed alcoholics and for the use o f  buspirone in treating anxious alcoholics. Malec. 
Malec and Dongier reviewed five trials o f  the use o f  buspirone for treating alcohol 
dependence and found some evidence for its use for treating anxious alcoholics. They 
concluded buspirone primarily reduced the comorbid anxiety symptoms.
The most recent review o f  the use o f  pharmacotherapy, by Garbutt, West, Carey, 
Lohr, and Crews (1999), used a meta-analytical technique to review 41 studies and 11 
follow-up or subgroup studies o f  five subgroups o f  medications including disulfiram, 
naltrexone and nalmefene, acamprosate, seratonergic agents, and lithium. They used a 
grading system to rate whether a drug was proven to be efficacious for treating alcohol 
dependence; an “A” indicated clear and consistent evidence that the drug was superior to 
placebo, a “B” indicated that the evidence was inconsistent, and the evidence was 
inconclusive regarding the efficacy o f  the drug, a “C” indicated that the evidence was 
sufficient and consistent to conclude that the drug was no more efficacious than placebo, 
and an “I” for inadequating evidence to make a conclusion regarding efficacy. Both 
Naltrexone and Acamprosate received grades o f  “A, ” indicating that there was definitely 
support for their use in treating alcohol dependence. Disulfiram received a grade o f  “B , ”
6
7indicating that the evidence was mixed regarding their use. Lithium received a grade o f  
“C, ” and, therefore, the conclusion was that there was no evidence to support its efficacy 
in the treatment o f  alcohol dependence. This same conclusion was also reached in 
another review o f  lithium treatment studies by Lejoyeux and Ades (1993). Seratonergic 
agents, received a grade o f  “I, ” indicating that the evidence was insufficient to make a 
conclusion regarding their use. This conclusion was based on the relatively small sample 
sizes o f  the studies, and the mixed nature o f  the results.
From these reviews o f  pharmacological studies, we can see that there was some 
evidence supporting the use o f  certain pharmacological treatments for alcoholism, 
particularly acamprosate, and perhaps opioid antagonists. However, there were also 
potentially promising pharmacologic agents that were still unproven such as SSRIs, 
while still others appeared to not be useful at all, such as Lithium. Finally, some studies 
found support for the use o f  pharmacologic treatments o f  comorbid disorders, such as the 
use o f  buspirone to treat a comorbid anxiety disorder. Some evidence suggested that 
treating comorbid mood disorders positively curtailed drinking.
Reviews o f  Single Nonpharmacological Treatments
Brief Intervention
Brief interventions were not necessarily one specific modality o f  treatment, but 
rather can be thought o f  as a “category” or “range” o f  interventions that were 
circumscribed and short-term (Heather, 1995). Brief interventions were, as the name 
suggested, short sessions or the provision o f  very few  sessions, with the goal o f  reduction 
o f  alcohol use. Typically, they were carried out in populations not seeking treatment, and
8in many cases, took place in a medical setting, such as a hospital emergency room or 
general practice. Eligible patients were screened for excessive alcohol use by one o f  a 
multitude o f  screening measures (such as the CAGE, AUDIT, or a structured clinical 
interview), and were usually then given feedback on their drinking. This feedback varied 
greatly in its content, but often focused on the deleterious consequences o f  drinking to 
the individual’s physical and/or mental health. Brief interventions were usually designed 
for patients with less severe alcohol problems, or who were in the early stage o f  
developing problems with alcohol. The goal was a quick, cost-effective method o f  
changing drinking behavior in a population for whom a longer, more costly intervention 
may not have been indicated.
Bien, Miller, and Tonigan (1993) conducted a meta-analysis o f  32 controlled 
studies o f  brief intervention. The studies ranged in follow-up from 3 to 120 months, with 
a mean o f  41. In studies comparing brief intervention to a control condition, an average 
effect size within the intervention groups (intake measure compared to post measure) o f  
. 70 was found, and further, an effect size comparing the intervention to control group o f  
. 38. In studies that compared brief intervention to a more intensive treatment, an average 
within-intervention group effect size o f . 8 was found (i. e., brief intervention pre to post). 
Also, a mean effect size involving the brief intervention group and more intensive 
treatment group o f . 06 was found.
A reasonable clinical interpretation is that, across studies, the intervention group 
showed a medium-to-large impact pre-post, that individuals receiving a brief intervention 
showed more improvement than those not receiving the intervention, and that individuals
receiving brief intervention did approximately as well as those receiving a more 
intensive, longer-term intervention.
Another meta-analysis reviewing 12 randomized controlled trials o f  brief 
intervention by Wilk, Jensen, and Havighurst (1997) found similarly positive results.
They computed odds ratios for effect sizes, and found approximately a two-to-one ratio 
in favor o f  brief interventions over control groups. That is, those who received brief 
intervention were twice as likely to moderate their drinking than were those in the control
groups.
Kahan, Wilson and Becker (1995) conducted a meta-analysis o f  11 controlled 
clinical trials o f  brief intervention by physicians. Follow-up for these studies ranged 
from 8 weeks to 6 years, the most common (six o f  the studies) being 1 year. They 
analyzed studies for validity, generalizability, and for outcome. They found that the four 
trials with the highest validity scores showed significantly reduced alcohol consumption 
by men between five and seven drinks per week. However, for women, only one o f  four 
studies found a significant reduction in drinking relative to control conditions (i. e., 
approximately three drinks per week). They also found little evidence to support a 
reduction in alcohol-related morbidity due to brief intervention; however, two trials did 
find a significant reduction in sick days.
A more recent meta-analysis o f  seven studies o f  brief intervention in primary care 
populations was conducted by Poikolainen (1999). The author separated brief 
interventions into two categories, very brief interventions (defined as one visit o f  5 to 20 
minutes), and extended brief interventions (defined as multiple visits). Poikolainen found 
no significant changes for men or women for the very brief interventions based on a 6- to
9
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12-month follow-up period. A  significant change o f  approximately four drinks per week  
was found for men and women who received an extended brief intervention. However, a 
lack o f  statistical homogeneity among the men studied implied that the summary estimate 
was not meaningful. The implication o f  this analysis was that the brief interventions 
were only truly effective for women, and only when more than one intervention visit
occurred.
It should be noted that conclusions drawn from the listed meta-analyses were very 
different. The last two were, in fact, in disagreement. It is also important to note that 
several authors have cautioned against reading too much into the results o f  controlled 
clinical trials and meta-analyses o f  brief interventions. Drummond (1997) stated that 
many o f  the studies o f  brief interventions have often excluded cases that could be 
regarded as having a poor prognosis and, therefore, results were inflated beyond which 
would actually be the case in practice. Further, Edwards and Rollnick (1997) pointed out 
that attrition rates in studies o f  brief intervention were very high (mean 70. 6%). Also, 
the drop-outs tended to show characteristics that were different from those who remained 
in the study (e. g., they were younger, heavier drinkers, and were less educated).
Relapse Prevention
Relapse prevention was a specific form o f  cognitive-behavioral therapy that 
focused on anticipating and coping with high-risk situations that may lead to a “relapse” 
or return to drinking (or other drug use).
A review o f  relapse prevention by Carroll (1996) reviewed this treatment’s use 
for the treatment o f  smoking, marijuana, cocaine, alcohol, and general drug use. Six
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studies o f  the use o f  relapse prevention to  treat alcohol misuse were reviewed, only one 
o f  which found positive results for the use o f  relapse prevention relative to control or 
other psychosocial treatment condition. In contrast, a more recent meta-analysis (Irvin, 
Bowers, Dunn, & Wang, 1999) o f  22 published and four unpublished studies (10 o f  these 
studies focused on the treatment o f  alcohol) found support for the use o f  relapse 
prevention as a means o f  treating substance use disorders in general. They obtained 
average effect sizes for the included studies using the correlation coefficient r. The 
largest observed effect size was for the treatment o f  alcohol, r - . 37. The r’s obtained for 
the treatment o f  other substances were. 27 for polysubstance abuse,. 09 for smoking, and
-. 03 for cocaine use.
Acupuncture
Acupuncture is the stimulation o f  acupuncture points by the insertion o f  needles. 
This process was thought to have “analgesic and/or tonic effects on internal organ 
function” (Brewington, Smith, & Lipton, 1994). This process is thought to have a 
therapeutic effect on certain physical ailments (e. g., pain).
Two reviews on the use o f  acupuncture have been published (Brewington et al.. 
1994; Moner, 1996). Between the tw o reviews, a total o f  three different controlled trials 
were listed. Two o f  the studies reviewed found positive effects on such outcomes as the 
number o f  drinking episodes, self-reported desire to drink, and, in one study, admittances 
to a detoxification unit were cut by half (Bullock, Culliton, & Olander 1989; Bullock, 
Umen, Culliton, & Olander, 1987). One other study found no support for the use o f  this 
treatment (W orner, Zeller, Schwarz, Zwas, & Lyon, 1992). Obviously, additional
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research is needed before conclusions can be drawn about the efficacy o f  this treatment
for alcohol misuse.
Transcendental Meditation
Alexander, Robinson, and Rainforth (1994) conducted a meta-analysis o f  the use 
o f  transcendental meditation (TM ) for the treatment o f  alcohol, cigarette, and illicit drug 
use. TM was described by the authors as a “simple mental technique which is practiced 
twenty minutes twice daily” (p. 21). They analyzed fourteen studies that utilized TM as 
treatment for alcohol misuse, and found an average d  effect size (relative to control 
condition) o f . 55, which can be considered a small-to-medium effect size. They 
compared this effect size to other meta-analyses o f  alcohol treatment programs including 
relaxation, preventive programs, preventive education programs, and DUI treatment 
programs, and found that TM had the largest average effect size compared to  these other 
programs. While comparing the TM studies to preventive and driver under the influence 
(D U I) treatment programs did not seem valid, the comparison to other relaxation 
programs would seem  an important one. Comparing TM to relaxation would show  
whether the relaxation and attention aspect o f  TM was responsible for the changes in 
drinking behavior. The meta-analysis o f  relaxation for the treatment o f  alcohol misuse 
revealed an average effect size o f .  15, which was markedly lower than the average o f . 55 
for TM. This suggested that TM  might be more effective than simple relaxation training. 
The authors also concluded that TM  had effects larger than other standard treatment 
programs. However, given the other programs Alexander et al. used to make this 
comparison, this seemed a dubious conclusion. It was also important to keep in mind
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that the samples treated evidenced alcohol misuse, subjects were not necessarily alcohol 
dependent. However, they also found some evidence that the effects o f  TM were 
cumulative, and that effect sizes increased at later outcome measurement periods. This
would seem to indicate that abstinence was maintained and increased over time, which
was not commonly seen in other alcohol treatments.
Alcoholics Anonymous
Alcoholics Anonymous (AA) was a popular alcohol treatment, which was usually 
in the format o f  voluntary croup attendance, and was built around following a 12-step 
program o f  recovery. Tonigan, Toscova, and Miller (1996) conducted a meta-analysis o f  
107 studies o f  the effectiveness o f  AA. A major finding o f  their study was the poor 
quality o f  the research on this form o f  treatment. Representative selection, random 
selection, and objective verification o f  self-report measures were seldom used in this 
body o f  research. They also found that many o f  the studies had poor statistical power to 
detect significant differences due to small sample sizes for to make conclusions with 
correlational data. Despite the weaknesses o f  this body o f  literature, they attempted to 
find conservative estimates o f  bivariate and moderator relationships among variables 
relative to utilization o f  AA and outcome. They found that there did seem to be a 
correlation between AA attendance and drinking outcome (. 22), a correlation which was 
even higher for outpatients ( . 31). This pattern was also seen for psychosocial adjustment 
( .  18 overall,. 25 for outpatients). They also found that, at least in well-designed studies, 
there appeared to be a relationship between severity o f  drinking severity and AA
affiliation (r =. 20). The weak methodology evidenced by this meta-analysis disallowed 
a clear assessment o f  the magnitude o f  the effect o f  A A  on drinking behavior.
Family Therapy
Family therapy was a broad range o f  interventions that in some way include other 
members o f  the family in the treatment process, rather than treating just the individual 
who presented for treatment.
Edwards and Steinglass (1995) conducted a meta-analysis o f  21 studies o f  family 
therapy for the treatment o f  alcohol misuse. They separated treatment outcomes into 
three phases, based on when the family was actually included in the treatment, initiation 
o f  treatment, primary treatment/rehabilitation. and aftercare. They found four studies 
relevant to phase 1, and found support in all cases for the helpfulness o f involving family 
members at the initiation o f  treatment. The outcome variable looked at in this phase was 
simply whether the alcoholic entered treatment. All studies showed that alcoholics were 
somewhat more likely to enter treatment if  other family members (usually a spouse) were 
involved, than if no family members encouraged them to enter treatment. Fifteen studies 
were analyzed to determine the effectiveness o f  family therapy in phase 2, or primary 
treatment. They found mainly positive results for inclusion o f  family members, again 
usually spouses, in this phase o f  treatment, finding average effect sizes between. 75 and 
. 86. However, they found that effect sizes declined overtim e to an average o f .  17 for the 
several studies that followed subjects more than a year. Only tw o studies were found that 
utilized family therapy in phase 3, or aftercare. Both o f  these studies found support for
14
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the use o f  family therapy during this phase o f  treatment, with an average effect size o f
. 94
Reviews or Meta-Analyses Comparing
Different Treatment Modalities
As mentioned earlier in the introduction, several meta-analyses o f  the alcohol 
treatment outcome literature have been conducted in the past ten years comparing the 
effectiveness o f  specific treatment modalities. The focus o f  this study was to serve as an 
update to these studies, as all were focused on the literature up to 1992. However, these 
meta-analyses also varied on the exhaustiveness o f  the studies they used for their 
analysis, and on the variables for which they coded. These reviews are compared in the 
coming paragraphs for their relative contribution to determining the efficacy/ 
effectiveness o f  treatment modalities for alcohol treatment. The goal o f  this comparison 
was to assess the possibility o f  replicating one o f  these studies to achieve the stated goal 
o f  updating the literature.
Agosti conducted two meta-analyses o f  the outcome literature (1994; 1995). Both 
o f  these analyses included published controlled clinical trials from 1974 to 1992 that 
utilized at least one measure o f  drinking as an outcome variable. In the 1994 study, odds 
ratios were computed for 15 studies, and Agosti concluded that only 3 o f  15 studies 
demonstrated efficacy. This conclusion was based on a cu t-off odds-ratio o f  greater than 
“2, ” which the author admitted was an “arbitrary threshold” that may be “too high”
(p. 761). The odds-ratios ranged from. 25 to 3. 2.
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Effect sizes were computed for the 1995 study, which ranged from 0 to 6 . 3 across 
the studies, with an average o f  1. 17. Combining all studies, experimental groups 
consumed approximately four drinks less per week.
While Agosti did compute effect sizes using odds ratios and standard mean 
difference effect sizes, his two reviews only included 12 and 15 studies, respectively. 
Whether due to his fairly strict exclusionary criteria, his use o f  only the Medline 
database, or other reasons, both reviews appear to be lacking in comprehensiveness. This 
was especially noteworthy when the large number o f  articles reviewed by other authors 
across the same time period was considered. Thus, while Agosti’s studies were perhaps 
well designed to measure certain aspects o f  the treatment outcome literature, they were
far from exhaustive.
Three other recent meta-analyses o f  alcohol treatment outcome literature were 
located by the present author (Finney & Monahan. 1996; Holder et al., 1991; Miller et al., 
1995). All utilized very similar methodologies. However, each review offered a 
different rank ordering o f  the effectiveness o f  treatment modalities, as can be seen when 
the top five modalities across the three studies were considered (see Table 1).
Many o f  the articles coded in the three studies overlapped. In fact Holder et al. 
and Finney and Monahan used basically the same set o f  studies. Therefore, the 
methodology o f  each study did make a difference in the amount o f  support shown for 
each modality.
Holder et al. (1991) developed a measure utilized in all three reviews called a 
weighted index. This index was obtained by subtracting the number o f  studies with 
negative results (showing no evidence that the treatment was effective) from the number
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Table 1
Top Five Ranked Treatment Modalities in Three Meta-Analyses
Finney & Monahan ( 1996) Holder at al. (1991) Miller el al. (1995)
1. Community reinforcement
2. Social skills training
3. Behavioral marital
4. Disulfiram implants
5. Marital, other
Social skills training 
Self-control training
Brief invention
Marital, behavioral
Community reinforcement
Brief intervention
Social skills training
Motivational enhancement 
Community reinforcement
Behavior contracting
o f  studies with positive results (showing evidence that the treatment was effective), and 
then adding one additional point for the number o f  studies more than two reporting 
positive results. For example, in Miller et al. (1995), studies o f  brief intervention showed 
17 positive results and 6 negative results. The weighted index would be (17 - 6) +15 or 
26. The logic o f  this index was that treatment modalities that had been more extensively 
studied would obtain a higher number on this index. Holder et al. (1991) then obtained 
cost information for each o f  the treatments by compiling a database o f  average costs from 
providers, insurance companies, state alcohol and drug abuse authorities, and self-insured 
employers (1991), to use a cost basis on which to compare the treatments. These figures 
(adjusted for inflation) were also used by Finney and Monahan (1996) and by Miller et 
al. (1995).
The Finney and Monahan (1996) study was a replication o f  the Holder et al. 
(1991) study with several changes. As noted earlier, Finney and Monahan used most o f  
the same articles as the Holder et al. study, but added some exclusion criteria such as a 
minimum 50% follow-up rate. They were also unable to obtain several studies used in 
the Holder et al. study. Furthermore, they added several computations to the weighted
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index to  obtain what they called the adjusted effectiveness index (AEin). This 
computation was made by first calculating the probability o f  obtaining a statistically 
significant result, a measure o f  statistical power. This was done by examining the 
following factors: number o f  tests for treatment effects, earliest follow-up point, one- 
versus two-tailed test o f  significance, use o f  at least one continuous (versus categorical) 
outcom e measure, sample size, error-term-reducing statistical techniques such as analysis 
o f  covariance or repeated measures ANOVA, and the strength o f  competition (the judged 
effectiveness o f  the alternative treatment or control group). This probability was then 
subtracted from the percentage o f  studies that obtained a positive result to obtain the 
AEin. Through this computation, Finney and Monahan obtained a different rank 
ordering o f treatments than did Holder et al., despite using a very similar set o f  studies.
Miller et al. (1995) evaluated articles up to 1992, and also utilized a new coding 
system beyond the weighted index. This coding system was more comprehensive, and 
included a number o f  variables not examined in either the Holder et al. or Finney and
Monahan review.
First, they examined the severity o f  alcohol use or dependence in the treatment 
population, which was not assessed in either o f  the other two studies (for exact ratings o f  
severity, see Appendix A). This seemed a very important variable to look at when 
determining the efficacy o f  treatments, but was previously overlooked. Furthermore, they 
assessed the experimental design o f  the studies, as well as methodological quality. Miller 
et al. then compared treatment modalities through computation o f  what they called the 
“cumulative evidence index. ” For each o f  the studies a product score was computed as 
the product o f  the outcome logic score (OLS) and methodological quality score (MQS).
The cumulative evidence score for each modality was then computed by adding all 
product scores o f  studies within that modality.
The OLS was a classification system for positive and negative results, which 
ranged from +2 to - 2  and which took into account quality o f  experimental design.
Studies with positive results based on stronger designs, such as using a placebo control, 
were given a score o f  +2, while those based on weaker designs, such as comparison to an 
alternative treatment were given a score o f +1. The same was true o f  results showing no 
evidence for positive effect o f  treatments. Negative results based on stronger 
experimental designs obtained an OLS o f  - 2 ,  while those based on weaker designs 
obtained an OLS o f - 1 . For the specific coding system, see Appendix A.
The methodological quality scale was a rating based on twelve factors. Group 
allocation was rated 0, 1, 2, 3 or 4; 4 being for randomization, 3 for within-subjects 
counterbalanced design. 2 for case-control or matching, 1 for quasiexperimental designs, 
and 0 if the treatment groups are unequal (these articles were not included in the present 
review).
Quality control was scored 0 or 1 depending on the presence o f  some form o f  
treatment standardization with a manual or training.
Follow-up rate was coded 0 if  less than 70% o f  the sample was followed-up at 
outcome, or i f  the follow-up period was less than 3 months; 1 if  between 70 - 85% was 
followed up at outcome; and 2 if  85 - 100% o f  the sample was followed-up at outcome.
Follow-up length was coded 0 if  the longest follow-up period was conducted at 
less than 6 months; 1 if  the follow-up period was between 6 and 11 months; or 2 if  the 
follow-up period was greater than 1 year.
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Contact was coded 1 if follow-up contact was conducted by phone or in person 
for greater than 70% o f  the sample; it is coded 0 if  these conditions were not met, or if  
follow-up was conducted with a survey or questionnaire.
Collaterals received a code o f  1 if  collateral interviews (som eone able to vouch 
for the drinking status o f  the person) were conducted in greater than 50% o f  subjects; it 
was coded 0 if  this condition was not met.
Objective verification was given a 1 i f  some method o f  objective verification o f  
drinking status was employed, such as blood-testing, breathalyzer, record review, and so 
forth; it was given a score o f  0 if objective verification was not utilized.
Drop-outs were given a score o f  1 if treatment drop-outs were included in at least 
some o f  the outcome statistics, such as with an intent-to-treat analysis; it was given a
score o f  0 if  this condition was not met.
Attrition was given a score o f  1 when cases lost to follow-up were accounted for, 
and at least considered in determining outcome; and a score o f  0 if  this condition was not
met.
Independent rater was given a score o f  1 when the interviewer at follow-up was 
blind to the treatment condition, and was not involved in the treatment o f  that individual;
a 0 if  this condition was not met.
Use o f  appropriate statistical analyses was awarded a score o f  1. A study was 
given a score o f  0 if  no statistical analyses were utilized, or if  they are inappropriate for
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the data.
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Multisite treatment was given a score o f  one if  the intervention was carried out in 
more than one site as a parallel replication. It was given a score o f  0 i f  the intervention 
was carried out in only one site.
Studies with positive findings added to the CES, while studies with negative 
results subtracted from the total CES. Therefore, modalities with a higher CES had 
received more positive support overall than other modalities with a lower CES.
Two important variables not coded by Miller et al. (1995) were patient exclusion 
criteria and “additional diagnosis. ” While these were important variables, it was 
important to note that these variables were measuring factors o f  severity o f  the patient 
population, which was, indeed, coded. For the above reasons, the Miller et al. review 
seemed to be the best choice for summarizing research results across studies, as it 
evaluated a greater number o f  contributing factors to treatment outcome. An extension 
o f  Miller's study should serve as a useful update o f  the alcohol treatment literature as it 
will help clinicians and researchers compare effectiveness o f  various treatment
modalities.
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RATIONALE FOR CURRENT STUDY
The present study is an update o f  the Miller et al. (1995) meta-analysis utilizing 
the same methodology and coding system. This coding system was chosen because it 
gave a more comprehensive rating o f  research studies for methodological quality, and 
evaluated more o f  the possible factors that may affect treatment outcome. The update o f  
this review may potentially discover changing trends in alcohol treatment outcome 
research and determine if such factors as methodological quality play a role in 
experimental effectiveness. Also, it will be more inclusive, incorporating the large body 
o f  outcome studies published since 1992.
Procedures for Current Study
Articles for this review were located using the PsychLit and MedLine databases. 
The key words for the search were “alcohol*. ” “treatment. ” “outcome, ” and the names o f  
the treatment modalities listed in the Miller et al. article and any other names o f  the
treatment modalities found in the literature. Reference lists o f  obtained articles and
relevant reviews o f  alcohol treatment were searched for other possible controlled trials or 
comparison studies. The goal was to do an exhaustive search o f  the literature for
controlled outcome studies o f  alcohol treatment.
Articles were excluded for several reasons. The first was if  subjects were 
diagnosed with other substance misuse disorders. Second, studies were excluded if  the 
control or comparison group utilized was not likely an equivalent group. Last, only one 
article was included based on one treatment sample. A  good example o f  this was data
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based on Project MATCH. A number o f  studies have been published based on data from  
the large study. Only one study was included in the present review (Project M ATCH, 
1996). This study was chosen because it was the most inclusive (in terms o f  including 
the entire sample) o f  all studies published to date from this project.
Based on the above inclusion and exclusion criteria, 100 studies o f  alcohol 
treatment outcome utilizing a control or comparison group were obtained for inclusion in
this review.
The articles were coded using the manual used by Miller et al. (1995) in What 
Works. A copy o f  this manual was obtained from Dr. Miller, and is included in Appendix 
B. The author rated seven articles included in the original review to establish that rating 
by the current author would be similar to that o f  Miller et al. Toward this end, articles 
were chosen to represent different treatment modalities including brief interventions, 
longer term psychosocial interventions, and medical interventions including psychotropic 
and antidisotropic medications. Specifically, the seven articles were Monti et al. (1990), 
Baker, Udin, and Vogler (1975), Baldwin, Heather, Lawson, Robertson, Mooney, and 
Braggins (1991), Bien, Miller, and Boroughs (1993), Glover and McCue (1977), M onti et 
al. (1990), and Powell, Penick, Lisdow, Rice, and McKnelly (1986). Table 2 shows the 
level o f  agreement o f  the present author’s codings relative to that o f  Miller et al. (1995). 
The first set o f  codings showed an overall inter-rater reliability o f . 81. However, it was 
found that the initial coding errors were due to a number o f  misunderstandings about the 
coding system, especially for follow-up rate, OLS, and Modality. Upon further 
inspection and better understanding o f  the coding system, agreement was reached on  all
variables.
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Table 2
Comparison of Initial Ratings by Present Author to Those o f Miller et al. (1995)
Variable
# o f
disagreement
Total
codings
Reliability
coeffient
Percent male 1 7 . 86
Age 0 7 1. 00
n size 2 7 . 71
Severity 2 7 . 71
Group allocation 1 7 . 86
Quality 1 7 . 86
Follow-up rate 3 7 . 57
Follow-up length 2 7 . 71
Contact 0 7 1. 00
Collaterals 0 7 1. 00
Objective verification 1 7 . 86
Drop-out rate 1 7 . 86
Attrition rate 2 7 . 71
Independent rater 1 7 . 86
Appropriate analyses 0 7 1. 00
Multisite 0 7 1. 00
Outcome logic score 6 14 . 57
Modality 4 14 . 71
Total 27 140 . 807
One other rater (Jamie Barton, an undergraduate student in Public Health) was 
trained by the author to use the Miller coding system to establish inter-rater reliability in 
the 100 new articles obtained for the current review. The present author explained the 
manual and coded five articles with her until she reached a level o f  proficiency. The 
author and trained rater met weekly to discuss the articles she had coded, and her ratings 
were compared to those o f  the author. All discrepancies in coding were recorded and 
then discussed until agreement on the correct coding was reached. Inter-rater reliability 
coefficients will be computed and reported for all variables. A  third party (Dr. David
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Stein) was consulted in cases that were not easily resolved. A detailed account o f  
discrepancies, and inter-rater reliability is included in the results section o f  this
document.
Analysis
The articles were first coded for treatment effectiveness (see Appendix A or 
rating system and decision rules). They were given an outcome logic score (OLS) o f  +2 
for strong evidence o f  a specific positive effect, +1 for evidence for a specific positive 
effect, -1 for no evidence o f  a specific positive effect, and - 2  for no evidence o f  a 
specific positive effect with stronger experimental designs.
The methodological quality scale (M QS) was then coded (described earlier in this 
literature review). This scale consisted o f  12 different variables (see appendix). It was 
constructed to give more weight to studies o f  better methodological quality.
For each o f  these studies, the OLS was then multiplied by the MQS giving each 
study a final product score. The product scores o f  each study in a particular modality 
were then added together to obtain the cumulative evidence score (CES) for that 
particular modality. Because the OLS could be either positive or negative, each study 
could either add to, or subtract from the CES. The CES would show the amount o f
evidence each modality had in the literature, relative to other modalities.
The methodological ratings, OLS and CES, were then entered into a database. 
This database included all scores for the 100 articles identified by the author, as well as 
the 206 studies coded by Miller et al. (1995) and included in the tables o f  individual 
modalities in What Works. Cumulative evidence scores for articles coded by the author
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and by Miller et al. were analyzed to attempt to find what the entire body o f  literature 
was suggesting, and also to determine any trends in the data. For example, it was clear to 
see that studies o f  pharmacological treatments for alcoholism had grown in number more 
than any other modality in the past 8 years.
To compare the relative effectiveness o f  each modality, a table o f  the rank order 
o f  cumulative evidence scores was then constructed. This table included the number o f  
studies with positive and negative findings, the means for methodological quality score, 
sample size and population severity for each modality, current CES, CES at the time o f  
the Miller review, the difference between these two CESs, and an effect size for the 
amount o f  change in this variable between these two reviews.
Miller et al. suggested a minimum o f  three studies for drawing any conclusions 
on efficacy. One or two studies was considered “too little basis for a conclusion 
regarding efficacy” (p. 17). This same minimum number was utilized in this review, and, 
therefore, the table was separated into modalities with more than two and modalities with 
two or less studies, as Miller did in his review. There are a number o f  modalities that, at
the time o f  the Miller review, had not received sufficient research attention to make a
conclusion, which have since had more than two studies published. Therefore, there are 
a number o f  modalities in the main table o f  this study, which had little or no published
research at the time o f  the Miller review.
Example Coding o f  One Article
For the reader to understand how  the coding system was applied, the following
example is offered (i. e., Chang, Wilkins-Haug, Berman, & Goetz 1999).
This particular article compared a brief intervention for changing drinking 
behavior in pregnant women with an assessment-only condition (a control condition 
because both groups got the same assessment). Therefore, the only modality which was 
coded for this article was brief intervention.
Chang et al. randomly assigned 250 women to the treatment. The study earned a 
score o f  “4” as group allocation involved random assignment. Because the intervention 
was carried out on all women, the percent male was zero. Mean age was reported for the 
entire sample as 30 . 7.
This particular sample was identified by screening obstetric clinic patients. 
Therefore, these women were not presenting for alcohol treatment per se. This was a 
nonclinical sample. However, they were identified by a screening measure as having 
possible alcohol problems (the T-ACE); therefore, they could be considered a “problem- 
drinker” population. Therefore, the severity rating was a “2” (see Appendix A for exact 
rating system).
Follow-ups were completed, on average, at 22 weeks (5 . 5 months) after initiation 
into treatment. As such this study was given a “0” for follow-up length, because it was 
less than 5 months. O f the original 250 subjects, 247 were followed-up on; therefore, the 
score for follow-up rate was “2, ” because the rate was greater than percent (and was 
greater than a 3-month follow-up)
The brief intervention was standardized by use o f  a treatment manual, so a “1” 
was given for quality control. The follow-up was conducted in person by an interviewer 
blind to  treatment assignment, therefore, the article was given a score o f  “1” for contact, 
and a score o f  “1” for independent interviewer. They also reported obtaining a collateral
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report at the time o f  follow-up, which obtained a score o f  “ 1” for the collaterals variable. 
N o  objective verification was reported, so this variable was given a score o f  “0 . ”
The statistical analyses included comparison o f  group means through chi-square 
analysis, survival analysis, and regression analysis. These seemed acceptable analyses 
for the data presented; drop-outs were included in these statistics and cases lost to 
attrition were enumerated and discussed. As such scores o f  “ 1” were given for statistical 
analysis, drop-outs, and attrition.
This intervention was carried out in only one hospital, therefore, the multisite 
variable is given a score o f  “0 . ”
While both groups showed a reduction in drinks/drinking day (reduction o f . 4  for 
assessment group,. 3 for intervention group), there was no statistically significant 
difference between groups. Furthermore, they did not differ in the number o f  drinking 
episodes ( . 7 for intervention, 1. 0  for assessment group), or on 5-minute APGAR scores 
for children that were bom (8 . 7 assessment vs. 8. 9 intervention). As such, there was no 
meaningful difference between these two groups on any study variable, and therefore the 
outcome o f  the intervention group was seen to  be equal to that o f  the control group, and 
the outcome logic score was coded as “-2. ”
The methodological quality score (M QS) was the sum o f  ail methodological 
variables, the product score was then the product o f  the MQS (13) and the OLS (-2); 
therefore, the product score w as - 2 6  (see Table 3). This number was then entered into 
the database as the only product score for this study.
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Table 3
Computation o f MOS and Product Score for Chang, 
Wilkins-Haug, Berman, and Goetz (1999)
Variables Product Score
Group allocation 4
Quality control 1
Follow-up rate 2
Follow-up length 0
Contact 1
Collaterals 1
Objective verification 0
Drop-outs 1
Attrition 1
Independent 1
Analyses 1
Multisite 0
MQS (sum o f  all above variables 13
OLS -2
Product (MQS*OLS) -26
Research Questions and Analysis
1.  What conclusions can we make regarding the efficacy o f  treatment modalities 
combining all articles coded in Miller et al. and the current review?
Conclusions were based on the rank ordering o f  treatment modalities’ CES. The 
CES gave an idea if the modality had generally been found in studies to be better than a 
control condition, and inspection o f  the rank order gave a good measure o f  research 
support received relative to other treatments.
It was difficult to establish a cutoff CES for determining efficacy because this 
decision must include other factors than just a final number. For example, in Miller’s
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review behavioral self-control training (BSCT) and systematic desensitization both had 
final CES scores o f  -7, which would lead one to consider them equally unsupported by 
research. However, upon closer inspection, this rating was based on 30 research studies 
for BSCT (14 finding positive results, and 16 finding negative results), and only 3 for 
systematic desensitization (1 positive and 2 negative). The conclusions reached on the 
efficacy o f  this modality were obviously very different given the amount o f  research 
attention it had received. Therefore, rather than setting a cutoff point, efficacy was 
determined on a case-by-case basis.
For modalities with 10 or more replications, factors affecting mixed outcomes 
will be discussed, and an attempt made to identify client characteristics or other variables 
that seem to be contributing to differential outcomes. Modalities with less than 10 
replications were also studied for variables affecting outcome, but there was insufficient
data to look for trends across these studies.
2. Do more recent studies support or contradict the conclusions reached by the 
Miller review regarding the efficacy o f  certain treatments?
Rank orderings o f  treatment modalities obtained in the current review were 
compared to those obtained by Miller et al. Cumulative evidence scores o f  each 
individual modality were also compared to determine if  some modalities that had a 
negative score in Miller's review, now had a positive score, and vice versa. Effect sizes 
comparing cumulative evidence scores were computed.
3. Does this body o f  research point to any association between patient, design,
treatment format variables and outcome?
Multiple regression was used to determine what relationships, i f  any, existed 
between patient and methodological variables and outcome o f  the studies including 
codings from both Miller’s and the current study. Statistical significance levels o f . 05
were used.
4.  Has the quality o f  research methodology improved over time?
Mean MQS scores were computed by decade and compared using analysis o f  
variance. Also, visual scanning o f  scatter plots and linear regression were used to 
determine any trend in methodological quality o f  this body o f  research. It was 
hypothesized that there would be a trend toward better methodological quality in more 
recent studies. Statistical significance levels o f . 05 were used.
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RESULTS
In the present review, 100 articles were found published since Miller et al. ’s 1995 
review that matched the desired criteria o f  a study o f  alcohol treatment outcome with a 
control or comparison group. From these 100 articles, 127 product scores were obtained 
for computation o f  cumulative evidence scores for each modality in the analysis. When 
combined with the Miller et al. (1995) database, there were a total o f  306 studies (several 
articles included more than one study), with 441 product scores for analysis.
Reliability o f  N ew  Codings
Reliability o f  coding was established for the 100 new articles obtained.
Agreement was reached on all codings with little inconsistency between raters. Table 4 
lists the number o f  initial disagreements for each coding variable and the percentage o f  
disagreements. The reliability coefficient was based on a total jV  o f  100 (the number o f  
articles) for all variables except outcome logic score (OLS) and modality, for which there 
was a total N  o f  127. This discrepancy is explained by the fact that OLS and modality 
were scored for every ratable modality, and a number o f  articles contained more than one 
ratable modality, while all other variables were only rated once per article.
Inter-rater reliability was quite high, ranging between. 82 and 1. 000, with an 
overall reliability o f . 887. This was a similar rate to that obtained by Miller et al. who 
found a mean agreement rate o f  approximately 87% between the author and the 
consensus reached between two other coders. A table o f  all codings in the current study 
is included in Appendix B, in which all initial disagreements are marked.
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Table 4
Summary o f  Inter-Rater Reliability o f  Codings
Variable
# o f
disagreement
Total
codings
Reliability
coeffient
Percent male 6 100 . 94
Age 8 100 . 92
n size 11 100 . 89
Severity 19 100 . 81
Group allocation 3 100 . 97
Quality J 100 . 97
Follow-up rate 18 100 . 82
Follow-up length 6 100 . 94
Contact 6 100 . 94
Collaterals 12 100 . 88
Objective verification 17 100 . 83
Drop-out rate 12 100 . 88
Attrition rate 16 100 . 84
Independent rater 14 100 . 86
Appropriate analyses 0 100 1. 000
Multisite 13 100 . 87
Outcome logic score 26 127 . 795
Modality 20 127 . 843
Total 210 1854 . 887
Notes on Combining Databases
It is important to note before discussing the cumulative evidence scores o f  
modalities that a number o f  numerical errors were found in the Miller et al. (1995) 
article. Specifically, this author found nine instances when the methodological quality
scores listed in the tables o f  individual treatment modalities did not match those listed in 
the appendix that included the ratings on all methodological quality variables. Table 5 
lists the five articles on which this mismatch seemed to occur, along with the nine
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Table 5
rabies Listed o f Methodological Quality Scores in Modality Tables and Appendix o f  
Miller el al. (1995)
Authors
Value listed
Table Appendix Modality(s)
Bowen (1970) 9 10 Psychedelic medication
E n ds(1957) 9 10 Social skills training
Client-entered psychotherapy
Jensen (1963) 4 5 Psychedelic medication
Mindlin (1965) 6 7 General alcoholism counseling 
Educational lectures and Aims
Rosenberg (1986) 7 8 Cognitive therapy
Relapse prevention
Client-centered psychotherapy
treatment modalities in which they were listed on the individual tables.
A decision was made to utilize the numbers listed in the appendix because it was 
the only source for codings on ail methodological variables included in the database.
Another place where there appeared to be an error was in the relapse prevention 
table (Miller et al., 1995, Table 2 . 8, p. 24). The product score for Obolensky (1984) was 
listed as -7, while the methodological quality score was 13, and the outcome logic score 
was -2 which should give a product score o f  -26.
There were several instances where it appeared that an incorrect publication year 
was listed in the tables, including Bien (1993) listed as 1992, Cooper (1988) listed as 
1978, Hayashida (1989) listed as 1969, Marlatt (1977) listed as 1975, Miller (1989) listed 
as 1990, and Persson (1989) listed as 1988. These years were corrected to reflect the 
correct publication year in the database. While these were minor changes, they would be
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important to later calculations looking at the trend o f  methodological quality over time.
Another change from Miler et al. ’s reported data was the product scores for 
Cooper 1988. A total o f  five product scores were reported for this article, one under 
systematic desensitization, two under educational lectures and films, and tw o under 
sensory deprivation (assuming that, as listed above, the listing o f  Cooper [1978] was a 
numerical error that was meant to be Cooper [1988]). This article included two studies 
into the effects o f  Reduced Environmental Stimulation Training (REST), a treatment 
modality that had its own category in the Miller coding manual; therefore, this study 
should likely have been coded with two product scores for REST. While it was true that 
REST combined sensory deprivation and an educational message under that condition, it 
seemed the whole o f  this intervention was very different than just the sum o f  its parts, 
and would be better coded as a separate modality. Furthermore, there was no aspect o f  
this intervention that was related to systematic desensitization; therefore, including it as 
such appears to be a mistake.
It was unlikely that any o f  these changes significantly altered the interpretation o f  
the data presented in Miller et al. (1995). However, these still seemed to be important 
changes in the interest o f  accuracy. A comprehensive review o f  all studies coded by 
Miller was not undertaken, as it goes beyond the scope o f  this thesis.
Psychometric Properties o f  Coded Variables
Table 6 is a listing o f  the number o f  variables coded (som e studies did not report 
some variables such as % male), the minimum and maximum values, and the means and
standard deviations o f  all variables included in the database. These values are based on
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Table 6
Psychometric Characteristics o f Coded Variables fo r  Entire Database
Variable
N
reported Minimum Maxiumum Mean
Standard
deviation
Age 269 16. 2 57. 0 39. 57 6. 29
% males 293 0. 00 100. 0 81. 69 21. 83
n size 306 4. 0 8275. 0 193. 11 558. 38
Severity' 306 1. 0 4. 0 3 . 16 . 84
Group allocation 306 0. 0 4. 0 3. 49 1. 09
Quality 306 0. 0 1. 0 . 76 . 43
Follow-up rate 306 0. 0 2. 0 1. 17 . 85
Follow-up length 306 0. 0 2. 0 1. 19 . 84
Contact 306 0. 0 1. 0 . 83 . 38
Collaterals 306 0. 0 1. 0 . 39 . 49
Objective 306 0. 0 1. 0 . 47 . 50
verification 306 0. 0 1. 0 . 88
Drop-out rate 306 0. 0 1. 0 . 72 . 45
Attrition 306 0. 0 1. 0 . 49 . 50
Independent 306 0. 0 1. 0 . 89 . 31
Analyses 306 0. 0 1. 0 .  12 . 33
Multisite 306 2. 0 17. 0 11. 41 2. 72
MQS 441 -2. 0 2. 0 -. 24 1. 65
OLS 441 -32. 0 34. 0 -2. 39 19. 67
Product scores
the entire database including all studies in the Miller et at. (1995) review as well as the 
current one. As in the reliability calculation reported above, most variables are reported 
once per study because they were coded only once per study. The exceptions are 
outcome logic score and product score as they were coded for each modality reported, 
and each study may have multiple modalities.
Summary o f  Cumulative Evidence Scores
The following sections focus on answering the first two research questions
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regarding the efficacy o f  treatment modalities, and whether more recent studies require 
different conclusions than those reached by Miller et al. (1995). Cumulative Evidence 
Scores (CES) are reported for each modality in rank order. These are also compared to 
the CES obtained in the Miller et al. study through the computation o f  effect sizes.
Table 7 is the summary o f  the means o f  important variables and the CES o f  
separate treatment modalities. Included in this table are both the number o f  studies with 
positive outcomes (Np) and negative outcomes (N n), the mean Methodological Quality 
Score, the mean Severity Rating, the sum o f  all product scores (Cumulative Evidence 
Score) for each modality for both the current review and the Miller review, and the effect 
size o f  the change in CES from the Miller review to the current one. Effect sizes are
based on the standard deviation o f  the Miller CES scores.
The treatment modalities are listed in rank order by the Cumulative Evidence 
Scores obtained combining the Miller and current reviews. Modalities with less than 
three studies are separated from the rest, as it was deemed that two studies was 
insufficient evidence upon which to draw a conclusion.
Mean age o f  subjects was not included on this table, as the mean o f  all studies 
was 39 . 11, and most modalities had means that fell in the mid 30s to mid 40s.
Considering this lack o f  variation in mean age o f  samples for modalities, it is not a 
variable that would add much information about the differential efficacy o f  these
treatments.
A somewhat similar pattern o f  rank orderings was obtained when adding articles 
since the last review o f  this type, with a number o f  changes. As listed earlier in Table 1, 
the rank ordering o f  the first five modalities in the Miller et al review was brief
Summary o f Cumulative Evidence Scores and Methodological Quality for All Modalities
Table 7
Treatment modality Np Nn
Mean
MQS
Mean 
% male
Mean
sev
Mean
a
Current
CES
Miller
CES
CES niter 
difference
Effect
size
Brief intervention 26 17 12. 81 69 2. 27 305 229 239 -10 -0. 12
Medication--GABA agonist 7 2 I3. 7X 78 3. 56 3 ,  1 140 — — —
Social skills training I I 5 11. 19 83 3. 75 55 126 128 -2 -0. 02
Community reinforcement 5 0 ,  3. 80 74 3. 20 39 112 80 32 0. 39
Behavior contracting 4 0 10. 75 97 3. 75 54 73 73 0 0, 00
Motivational enhancement 8 6 12. 86 67 2. 57 223 72 87 -15 -0. 18
Cue exposure 3 1 11. 50 89 3. 50 59 35 — — —
Aversion, nausea opomorphone 3 3 10. 33 93 3. 83 201 34 34 0 0. 00
Psychotherapy, client-centered 3 2 10. 60 92 3. 20 100 23 34 - I I -0. 13
Aversion, covert sensitization 3 5 IO. XX 85 3. 50 63 18 18 0 0. 00
Marital/familv cog-behavioral 3 2 13. 40 91 3. 60 46 15 15 0 0, 00
Self-help 2 4 11. 83 58 2. 83 76 0 33 -33 -0. 40
Disulfiram It) 12 11. 00 88 3. 77 151 -7 9 -16 -0. 20
Acupuncture 1 2 10. 00 86 3. 33 61 -8 20 -28 -0. 34
Cognitive therapy 6 9 11. 47 74 3. 33 180 - I I 22 -33 -0. 40
Marilal/faniily non-behavioral 4 5 12. 56 74 3. 78 75 -12 -22 10 0 . 12
Behavioral self-control training 15 IX 12. 94 76 2. 88 72 -17 -7 -10 -0. 12
Medication--narcotic antagonist 3 4 11. 43 78 3. 14 89 -24 — — —
Aversion, electrical 6 9 11. 13 90 3. 73 77 -25 -25 0 0. 00
Medication-lithium 3 4 11. 14 91 3. 7, 123 -28 -8 -20 -0. 24
Relapse prevention 3 X 12. 00 87 3. 09 62 -31 34 -65 -0. 79
Functional analysis 0 3 11. 33 87 2. 67 119 -34 -22 -12 -0, 15
Hypnosis 0 4 10. 25 199 3. 75 119 -41 -41 0 0. 00
Milieu therapy 
Medication-antidepressant
3 7 11. 70 89 3. 60 , 05 -41 -41 0 0. 00
2 5 11. 14 74 3. 00 121 -44 -24 -20 -0. 24
Medication-psychedelic 2 6 10. 13 99 3. 63 123 -44 -45 1 0. 01
Standard treatment--n. o. s. 0 3 , 0. 67 90 3. 00 804 -53 -53 0 0. 00
Alcoholics Anonymous 0 3 12. 33 87 3. 33 169 -63 -52 - I I —
Medication-SSRI 4 X 11. 83 76 3. 17 66 -73 — — —
Medication-dopamine agonist 0 3 12. 33 94 3. 33 209 -74 — — 0, 00
Videotape self-confrontation 0 6 10. 83 97 3. 8. 3 53 -77 -77 0 —
Medication-seratonin antagonist 0 4 11. 75 87 2. 75 264 -94 - — 0. 00
Metronidazole 1 10 9. 64 94 3. 73 64 -102 -102 0
(table continues)
00
Mean Mean Mean Mean Current Miller CES rater Effect
Treatment modality Np Mt MQS % male sev n CES CES difference size
Psychotherapy-insight-oriented 2 10 11. 67 89 3. 17 411 -132 -127 -5 -0. 06
Confrontational counseling 0 ft 11. 50 90 2. 88 136 -135 -125 -10 -0. 12
Relaxation training only 3 13 10. 94 89 2. 88 47 -139 -109 -30 -0. 37
Medication-antianxiety 1 I I 9, 25 89 3. 25 181 -183 -79 -104 -1. 27
Counseling-general alcoholism 1 15 11. 38 87 3. 50 146 -215 -215 0 0. 00
Educational lectures or films 3 18 10. 14 79 2. 33 866 -247 -239 -8 -0. 10
Modalities will, I wo or fewer studies
Tobacco cessation treatment 2 0 11. 00 71 3. 00 333 44 - — -
Reduced environmental 2 0 10. 00 46 1. 00 55 40 - - -
Stimulation training — — — — — — — — — —
Developmental counseling 1 0 14. 00 53 2. 00 144 28 28 0 0. 00
Case management 1 0 1. 3. 00 81 4. 00 298 26 .. — —
Medication-dopamine antagonist 1 0 12. 00 — 4. 00 100 24 — — —
E G  biofeedback 1 0 11. 00 100 4. 00 250 22 — — —
Transcendental meditation 1 0 11. 00 100 4. 00 250 22 — — —
Feedback of assessment 1 0 10. 00 52 2. 00 26 20 — — —
Nurse intervention 1 0 10. 00 100 3. 00 127 20 — —
Contingency management 1 0 10. 00 81 3. 00 42 20 - -
Systematic desensitization 2 0 11. 50 96 4. 00 39 13 07 20 0. 34
Detoxification 1 0 12. 00 78 4. 00 95 12 — — —
Exercise 1 1 10. 50 100 2. 50 53 9 9 0 0. 00
Aversion-apneic 1 1 10. 00 0 3. 50 44 0 0 0 0. 00
Occupational therapy 0 1 12. 00 69 3. 00 229 -12 — -- —
Problem-solving 0 1 12. 00 62 4. 00 90 -12 -12 0 0. 00
Twelve-step facilitation 0 1 16. 00 76 3. 00 1726 -16 — — —
Kudzu root 1 0 10. 00 98 4. 00 49 -20 — — —
Self-monitoring 1 1 12. 50 69 3. 50 28 -23 -23 0 0. 00
BAC discrimination training 0 2 12. 00 92 3. 50 79 -24 -24 0 0. 00
Medication-beta blockers 0 1 13. 00 - 4. 00 100 -26 — — —
Assessment as intervention () 1 15. 00 57 2. 00 378 -30 — — —
Calcium carbimide 0 2 10. 00 97 4. 00 40 -32 -32 0 0. 00
Medication-antipsychotic (I 2 9. 00 89 3. 50 442 -36 -36 0 0, 00
Neurotherapy 0 2 11. 00 100 3. 50 159 -44 — .. ••
Total database 170 271 11. 56 82 3. 17 186 -1052 -684 -368 -2. 83
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intervention, social skills training, motivational enhancement, community reinforcement, 
and behavior contracting. The five top-ranked treatments in the current review are brief 
intervention, GABA agonist medication, social skills training, community reinforcement, 
and behavior contracting. Four o f  the five rankings remained the same, with 
motivational enhancement only falling slightly. However, support for G ABA agonist 
medication represents a new addition; there were no studies o f  GABA agonist medication
available at the time o f  the Miller et al. review.
Treatment Modalities Included in This Review
Table 8 includes brief descriptions o f  all treatment modalities for which there are 
conclusions are made in this review (i. e., more than tw o studies were found o f  the 
modality). Table 8 allows the reader to better understand the major features o f  each 
treatment modality. They are presented in the same order as Table 6.
Summary o f  Ratings by Article for Each Modality
The tables that follow include all codings from both the present review and Miller 
et al. (1995). For each modality, studies are listed including the author, year published, 
sample size, rating o f  sample severity, methodological quality score (M QS), outcome
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Table 8
Summary o f Treatment Modalities
Treatment Modalities
Brief intervention Short 15-20 minute interventions with the goal o f reducing drinking Subjects are usually 
identified by a quick screening measure, as as the A U D IT  or CAGE.
Medication—GABA  
agonist (acamprosate)
A  psychotropic medication that acts to increase levels o f the GABA neurotransmitter. It 
is proposed to reduce the aversive effects o f alcohol abstinence, and reduce craving 
(Swift. 1999).
Social skills training The goal o f social skills training is to address psychosocial deficits that help to maintain 
drinking behavior. Social skills training can include such topics as assertiveness, 
initiating conversations, listening giving and receiving criticism, and drink refusal skills.
Community
reinforcement
Based on the approach o f Aznin. community reinforcement is a complicated intervention 
that requires the participation o f a spouse, family, or other involved community member 
who serves to change the contingencies for reinforcement in the alcoholic's life. These 
significant others work to reinforce the person in treatment for sober behavior, and to 
avoid reinforcing them for drinking. This runs concurrent to the person's own work in 
therapy.
Behavior contracting A straight-forward approach o f agreeing to a set o f behaviors the person will or will not 
do. and writing out a contract that spells out those behaviors.
Motivational
enhancement
A specific form o f brief intervention that utilizes motivational enhancement techniques as 
described by Miller and Rollnick (1991). It is often focused on perceived drinking norms 
and alcohol expectancies.
Cue exposure An intervention that focuses on the classically conditioned cues for drinking. A  person is 
usually exposed to graduated cues for drinking (e. g .  a bottle in front o f them, the smell o f  
alcohol, etc. ). Exposure to these cues is paired with a relaxation response, rather than 
drinking
Aversion, nausea 
apomorphine
Alcohol is paired with a nauseous Ceding chemically induced through the use o f  
apomorphine. The goal is to classically condition nausea responses with alcohol, 
therefore reducing cravings to drink when facing stimuli that ordinarily leads to drinking 
behavior.
Psychotherapy -  
client centered
Nondirective therapy in which the therapist treats the person with unconditional positive 
regard. Based on the original work o f Carl Rogers.
Aversion- 
covert sensitization
Covert sensitization is a means o f pairing images o f noxious stimuli with alcohol. For 
example, alcohol may be paired with imagery o f vomiting and Ceding sick.
Marital/family 
cognitive-behavioral
Therapy that incorporates a spouse and/or family members that utilizes cognitive 
behavioral techniques, and focuses on family relationships and their intervention with 
drinking behavior.
Self-help Self-help is usually in the form o f bibliotherapy. which stands on its own without other 
intervention.
Disulfiram
(Antabuse)
An aversive agent, it serve to increase levels o f acetaldehyde levels when drinking and 
therefore increases aversive effects o f  alcohol consumption.
(table continues)
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Treatment Modalities
Acupuncture Acupuncture is an ancient Chinese technique o f stimulating specific external body parts, 
usually by needle insertion. These external body locations arc thought to be 
interconnected with other body organs, and acupuncture is thought to alleviate disease 
(Moner. 1996).
Cognitive therapy Cognitive therapy seeks to address maladaptive cognitions that lead Io drinking through a 
number of common techniques. The goal o f this type of intervention with alcoholics is to 
discover the cognitive thought patterns or distortions that play a role in maintaining 
drinking behavior. Cognitive therapy is usually accompanied by a number o f  behavioral 
techniques such as self-monitoring, and relaxation training aimed at drinking reduction.
Marital/Familv
nonbehavioral
Any form of therapy that includes a spouse or other family members, but is not 
behavioral in nature. One common example is a family systems intervention.
Behavioral 
self-control training
Focused on teaching individuals to moderate their drinking, and to drink at a
nonproblematic  level. Common aspects o f treatment include goal-setting, self­
monitoring. plus establishing rewards for meeting the set-out goals. Teaching o f alternate 
coping strategies for drinking situations (similar Io relapse prevention) is usually included 
as well.
Medication-narcotic
antagonist
(Naltrexone)
Blocks the opioid receptors in the brain, reduces pleasurable effects o f drinking and 
decreases craving.
Aversion, electrical Pairing alcohol with electrical shocks in order to classically condition an aversive 
emotional reaction to future alcohol exposure.
Medication—Lithium Usually associated with bipolar disorder, acts on a number o f neurotransmitters, including 
seratonin. dopamine, and norepinephrine among others.
Relapse prevention A specific form o f cognitive-behavioral therapy that focuses on the cutes that trigger 
relapse, and encourages the person in treatment to plan how they will deal with high risk 
(relapse) situations (i. e.. i f  you see an old friend you used to drink with, what will be your 
thoughts? what will you do? ).
Functional analysis Functional analysis is a specific form o f behavioral assessment and intervention that takes 
into account the context o f behaviors, what the purpose o f that behavior is within that 
context, and how changes in that behavior will impact the person's environment.
Hypnosis A  form of therapy in which post-hypnotic suggestions focus on the person not drinking.
Milieu therapy An intervention based on creating a therapeutic atmosphere for clients, which is in itself 
globally therapeutic. It is usually an inpatient or residential unit where treatment is the 
focus at all times. There is usually frequent group therapy contact and a focus on how 
people interact socially.
Medication-
antidepressant
(imiprimine)
These are the “old" style-antidepressants, such as imipramine. They act mainly on the 
seratonin and norepinephrine neurotransmitters, and help to alleviate depression and 
anxiety.
Medication-
psychedelic
These are medications that have a psychedelic impact on brain functioning such as
Lysergic Acid (LS D ). Studies o f this type stopped a number o f years ago.
Standard treatment— 
ILO. S.
A catch-all category tor treatments that are not specified beyond how the treatment is 
usually carried out. often as a comparison condition.
(table continues)
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Treatment Modalities
Alcoholics
Anonymous
A  commonly recommended intervention in the United States what utilizes the 12-stcp 
model o f addiction recovery. Treatment is not completely standardized, but usually 
includes attendance o f 12-step meetings and obtaining a lay "sponsor”  (an individual 
more advanced in their recovery) who helps the individual maintain abstinence and 
guides him/her through the steps. AA is usually included as an adjunct to formal 
treatment programs.
Medication—SSR1 
(Prozac. Zoloft)
This class o f medications prevents the reuptake o f seratonin. therefore increasing the 
amount o f seratonin in the synapse. They act to reduce depression and anxiety.
Medication- 
dopamine agonist 
(bromocriptine)
These medications increase the amount o f the neurotransmitter dopamine, and arc 
thought to possibly reduce the unpleasant effects o f abstinence.
Videotape
self-confrontation
An intervention in which the person is videotaped while they are drinking, or drunk, and 
then shown that videotape later to show them how their behavior changes while they are 
drinking.
Medication-seratonin 
antagonist (ritanserin. 
odansetron)
These medications decrease levels o f seratonin. the mechanism o f  action is not 
understood, but it has shown some efficacy in reducing alcohol consumption in animals 
(Johnson. 1996).
Metronidazole This is another aversive agent that acts to increase the unpleasant effects of alcohol.
Psychotherapy- 
insight oriented
Insight-oriented psychotherapy utilizes one o f the psychodynamic approaches to therapy. 
and is focused on the individual in treatment having "insight’' or understand the reason 
why they behave as they do. The purpose o f this type o f intervention is that when the 
person has this "insight. ” they will then change their behavior.
Confrontational
counseling
This form o f intervention is based around "confronting the drinking behaviors o f the 
person. It often includes a number o f family members and friends who tell the person 
how the person's drinking effects them.
Relaxation training 
only
The use o f Progressive Muscle Relaxation (P M R ) or imagery techniques to achieve state 
o f relaxation. People are generally instructed to utilize this technique regularly, often 
daily. The goal is to reduce stress, which, in turn, may decrease the use o f alcohol.
Medication-anti­
anxiety
Anti-anxiety medication such as Buspar has been tried as a means o f  reducing anxiety 
that may lead to sell-medicating behaviors. A  number o f anxiolytic medications are habit 
forming (the benzodiazapines). and. therefore, inappropriate for this population.
Counseling- 
general alcoholism
This is somewhat a catch-all category for interventions in which counseling that focused 
on alcoholism was given, but was not further specified.
Educational lectures 
or films
Interventions focused on giving information about the effects o f  drinking in a film or 
lecture format Designed on the basis that people, when armed with information about 
the destructive nature o f their behavior, will then change that behavior.
logic score (OLS), product o f  MQS and OLS, and who the study was coded by (Miller or 
the present author). The Cumulative Evidence Score, the sum o f  all product scores, is 
also listed for each modality. The modalities were grouped together in tables based on 
similarity o f  intervention. For example, brief intervention and motivational enhancement
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are listed together, as motivational enhancement is usually a form o f  brief intervention. 
The grouping o f  modalities is similar to that utilized in Miller et al. (1995). This 
information is also presented relevant to the first tw o research questions regarding the 
efficacy o f  the various treatment modalities.
Table 9 shows ail o f  the individual codings for studies o f  brief intervention and 
motivational enhancement. A great deal o f  support for brief intervention and 
motivational enhancement has persisted since the time o f  the Miller et al review. This 
persistence o f  support is impressive as is the amount o f  study these two types o f  
intervention have received (43 total for brief intervention, 14 total for motivational 
enhancement). The mean sample sizes o f  the studies completed (305 for brief 
intervention, 223 for motivational enhancement) also reflect significant generalizability
o f  effects.
However, despite these positive results and the seeming generalizability, it is 
important to note for whom this type o f  intervention has proved effective. The mean 
population severity for brief intervention and motivational enhancement studies are 2 . 28 
and 2 . 57, respectively, compared to the overall mean severity rating o f  all studies o f  3 .  17. 
The 2. 28 mean severity rating for brief intervention is the lowest mean severity for any 
modality for which there have been three or more studies completed. Therefore, brief 
intervention and motivational enhancement work better than comparison or control 
conditions only for less severe populations (i. e., subjects who likely do not meet 
diagnostic criteria for alcohol dependence).
This is still a very meaningful result from a public health perspective given the
limited resources that are required for such programs, relative to the significant changes
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Table 9
Studies o f  Brief Intervention and Motivational Enhancement
Review
Author Year n size Severity M Q S OLS Product author
Fleming 1999 158 2 16 2 32 Tranchita
Fleming 1997 774 16 2 32 Tranchita
Harris 1990 34 3 16 2 32 Miller
Man well 2000 205 2 16 2 32 Transchita
Wallace 1988 909 2 16 2 32 Miller
Israel 1996 105 2 15 2 30 Tranchita
Babor 1992 1490 2 14 2 28 Miller
Marian 1998 456 1 14 2 28 Tranchita
Anderson 1992 154 13 2 26 Miller
W H O 1996 1559 ** 13 2 26 Tranchita
Chick 1985 156 2 12 2 24 Miller
Elvy 1988 226 -> 11 22 Miller
Heather 1996 174 2 11 2 22 Tranchita
Kristen son 1983 473 2 11 2 22 Miller
Maheswaran 1992 44 2 11 2 22 Miller
Persson 1989 71 10 2 20 Miller
Tom son 1998 222 10 20 Tranchita
Welte 1998 673 2 10 2 20 Tranchita
Chick 1988 152 3 16 1 16 Miller
Edwards 1977 100 3 15 1 15 Miller
Sanchez-Craig 1991 96 3 15 1 15 Miller
Chapman 1988 105 4 14 1 14 Miller
Sanchez-Craig 1989 90 3 14 1 14 Miller
Sannibale 1988 96 ** 14 1 14 Miller
Zweben 1988 218 3 14 1 14 Miller
Obolensky 1984 96 2 13 1 13 Miller
Reynolds 1995 78 2 8 -I -8 Tranchita
Daniels 1992 233 5 . 2 -10 Miller
Richmond 1999 852 1 5 _2 -10 Tranchita
Hayashida 1989 164 3 12 -1 -12 Miller
Romelsjo 1989 83 3 12 -1 -12 Miller
Robertson 1986 37
-V 14 -1 -14 Miller
Richmond 2000 688 1 9 _2 -18 Tranchita
Bennie 1998 95 4 12 -2 -24 Tranchita
Aalto 2001 296 2 13 . 2 -26 Tranchita
Aalto 2000 118 2 13 . 2 -26 Tranchita
Burge 1997 242 13 . 2 -26 Tranchita
Chang 1999 250 2 13 . 2 -26 Tranchita
Scon 1990 72 2 13 . 2 -26 Miller
Monti 1999 94 2 14 . 2 -28 Tranchita
Heather 1987 104 3 15 . 2 -30 Miller
Richmond 1995 378 2 15 . 2 -30 Tranchita
Senft
CES =  +  229
1997 516 2 15 _2 -30 Tranchita
(table continues}
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Author Year n size Severity’ MQS OLS Product
Review
author
Motivational Enhancement
Miller 1993 42 2 15 2 30 Miller
Miller 1988 42 2 15 2 30 Miller
Bien 1993 32 4 13 7 26 Miller
Brown 1993 28 4 13 2 26 Miller
Sanchez-Craig 1996 155 3 12 24 Tranchita
Heather 1996 174 2 11 2 22 Tranchita
Mallams 1982 40 3 10 7 20 Miller
Borsari 2000 60 1 9 18 18 Tranchita
Baer 1992 132 2 I I -11 -11 Tranchita
Kuchipudi 1990 114 3 13 -13 -13 Miller
Project M A T C H 1996 1726 3 16 -16 -16 Tranchita
Handmaker 1999 42 2 11 -22 -22 Tranchita
Richmond 1995 378 2 15 -30 -30 Tranchita
Chick
C E S -+72
1988 152 16 -32 -32 Miller
in drinking behavior that can occur across large numbers o f  people.
It is also apparent from this review that studies o f  psychotropic medications have
become far more numerous since the time o f  Miller's review, more so than any other 
modality. Specifically, at the time o f  the Miller et al. (1995) review, there were 26  
codable outcomes o f  psychotropic medications, accounting for 8. 2% o f  all those obtained 
in the review. In the current study, there were a total o f  73 codable outcomes o f  
psychotropic medications, accounting for 16. 5% o f  the total codable outcomes. Even 
more striking is the number o f  codable outcomes o f  psychotropic medications from new  
studies completed since the Miller review. In the new articles compiled by the present 
author, there were 47 codable outcomes o f  psychotropic medications, accounting for 37% 
o f  the total in the 8 or so years between the Miller et al. (1995) review and the current 
one. Table 10 shows all o f  the codings for studies o f  psychotropic medications.
What has this increased research attention taught us about the use o f  psychotropic
medication to treat alcohol misuse? First, all but one o f  the medications have negative
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Table 10
Studies o f  Psychotropic Medications
Author Year n size Severity M QS OLS Product
Review
author
GABA-agonists (Acamprosate)
Paille 1995 38 3 15 30 Tranchita
Sass 1996 272 4 15 2 30 Tranchita
Poldrugo 1997 246 4 14 2 28 Tranchita
Tempesta 2000 330 14 28 Tranchita
Whitworth 1996 455 4 14 2 28 Tranchita
Gallimberti 1992 82 4 13 2 26 Tranchita
Pelc 1997 188 3 12 2 24 Tranchita
Chick A 2000 581 3 13 . 2 -26 Tranchita
Besson 1998 110 4 14 .  2 -28 Tranchita
CES -  140
Narcotic antagonist (Naltrexone. Nalmefene)
Anton 1999 132 3 12 *> 24 Tranchita
Mason 1994 21 3 11 2 22 Tranchita
Volpecelli 1992 70 4 11 2 22 Tranchita
Kranzler 1998 20 3 11 . 2 -22 Tranchita
Volpecelli
Chick B
1997 98 11 -> Tranchita
2000 175 12 -24 Tranchita
O’Malley
CES -  -24
1996 104 *
Lithium
12 -v -24 Tranchita
Fawcett 1987 104 4 15 2 30 M iller
Kline 1974 73 4 9 2 18 Miller
Merry 1976 71 4 8 16 Miller
Malec. T. S. 1994 40 3 10 . 2 -20 Tranchita
Pond 1981 47 10 -20 Miller
Powell 1986 100 4 10 . 2 -20 Miller
Dorus 1989 426 4 16 .  2 •3 - Miller
CES =  -28
Psychedelics (Lysergic Acid)
Hollister 1969 72 4 11 1 11 M iller
Jensen 1963 125 4 5 2 10 Miller
Tomsovic 1970 333 3 7 - I -7 M iller
Bowen 1970 87 3 10 - I -10 Miller
Rhead 1977 103 4 11 -1 -11 Miller
Bowen 1970 59 3 12 - I -12 Miller
Smart 1966 30 4 12 - I -12 M iller
Ludwig 1969 176 4 13 - I -13 M iller
CES = -44
{table continues)
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Author Year n size Severity MQS OLS Product
Review
author
Anti-depressants (imipramine or Tofranil. desiprimine or Norpramin)
Mason 1996 71 3 15 2 30 Tranchita
Nunes 1993 26 3 13 2 26 Tranchita
Kissin 1968 288 3 2 . 2 -4 M iller
Shafter 1964 145 3 10 «2 -20 M iller
Powell 1995 216 3 11 . 2 Tranchita
McGrath 1996 69 3 12 . 2 -24 Tranchita
Mueller 1997 29 3 15 . 2 -30 Tranchita
CES = -44
Seratonin reuptake inhibitors
(fluoxetine or Prozac, sertraline or Zoloft, citalopram or Celexa)
Romach 2000 136 3 I I .  2 -22 Tranchita
Roy-Byrne 2000 64 3 10 .  2 -20 Tranchita
Angelone 1998 81 4 11 22 Tranchita
Cornelius 1997 51 4 14 28 Tranchita
Janiri 1996 50 3 12 24 Tranchita
Tiihonen 1996 62 3 12 . 2 -24 Tranchita
Cornelius 1995 21 3 12 2 24 Tranchita
Kranzler 1995 101 3 15 -1 -15 Tranchita
Naranjo 95 A 1995 99 3 I I .  2 _22 Tranchita
Balldin 1994 63 3 11 -22 Tranchita
Kranzler 1993 19 11 -22 Tranchita
George 1992 45 *♦3 12 -24 Tranchita
CES -  -73
Dopamine agonists (bromocriptine)
Powell 1995 216 3 11 _2 Tranchita
George 1992 45 3 12 . 2 -24 Tranchita
Naranjo 1997 366 4 14 «2 -28 Tranchita
CES -  -74
Seratonin antagonists (ritanserin. odansetron)
Naranjo 95 B 1995 42 1 11 _2 . 09 Tranchita
Sellers 1994 96 3 11 «2 -22 Tranchita
Johnson 1996 423 3 12 -2 -24 Tranchita
Wiesbeck 1999 493 4 13 . 2 -26 Tranchita
CES = -94
Anti-anxiety (buspirone or Buspar. chlordiazapoxide or Librium)
H off 1961 100 3 5 2 to Miller
Kissin 1968 288 3 2 _2 -4 M iller
Gallant 1968 78 4 9 4 -9 M iller
Shaffer 1963 199 4 10 -1 -10 Miller
Martholomew 1961 40 ** 6 . 2 -12 M iller
Mooney 1961 214 3 6 . 2 -12 M iller
Charno ff 1963 835 3 10 _2 -20 M iller
Powell 1985 174 3 11 . 2 -22 M iller
George 1999 53 3 12 . 2 -24 Tranchita
M ake. E. 1996 57 4 12 . 2 -24 Tranchita
Malcolm 1992 67 3 13 . 2 -26 Tranchita
Kranzler 1994 61 3 15 -30 Tranchita
CES = -183
(table continues)
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Author Year n size Severity MQS OLS Product
Review
author
Shaw 1994
Dopamine antagonies (tiapride)
100 4 12 2 24 Tranchita
CES = 24
Gottlieb 1994
Beta-Mockers (Atenolol)
100 4 13 . 2 -26 Tranchita
CES = -26
Reinert 1958
Antipsychotics (reserpine)
48 4 8 -2 -16 Miller
Charnoff 1963 835 3 10 . 2 -20 Miller
CES -  -36
cumulative evidence scores. This indicates that on the whole, they do not do statistically 
significantly better than placebo in reducing alcohol use. Furthermore, none o f  the 
medications studied at the time o f  the Miller review had a positive effect size in CES in
the current review.
One exception was GABA agonist medication (acamprosate). Nine recent (since 
the time o f  the Miller review) controlled studies o f  G ABA agonists were located for the 
current review. O f the nine, seven found positive results, giving G ABA agonist 
medication the second highest cumulative evidence score o f  all modalities. Even more 
intriguing is the average sample severity across these nine studies was 3 . 56 (all sample 
severities were either 3 or 4). This indicates that these medications help to make 
statistically significant reductions in alcohol consumption among people with more 
severe alcohol problems. Such individuals are likely to be diagnosed with at least an 
alcohol misuse disorder, often moderate to severe dependence.
As can be seen in Table 11, studies o f  antidisotropic medications have nearly 
ceased to  be published in the years since the Miller review. Only one controlled study
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Studies o f Antidisotropic Medications
Table 11
Author Year ft S\2£ Severity- MQS OLS Product
Review
author
Fuller 1986 605
Disulfiram (Anabuse)
4 17 34 Miller
Azrin 1982 43 4 14 28 Miller
Chick 1992 126 4 14 2 28 Miller
Wilson 1978 20 4 13 A 26 Miller
Wilson 1980 100 4 12 2 24 Miller
Wallerstein 1957 178 4 9 2 18 Miller
Whyte 1974 45 4 7 16 Miller
H o ff 1953 792 4 5 2 10 Miller
Reinert 1958 48 4 8 1 8 Miller
Hussain 1972 43 * 6 1 6 Miller
Gerrein 1973 121 4 6 -1 -6 Miller
Aharan 1967 116 3 8 -I -8 Miller
L e w 1967 30 4 8 -I -8 Miller
Ludwig 1969 176 4 13 -1 -13 Miller
Fuller 1979 128 16 -I -16 Miller
Smith 1998 106 4 16 -1 -16 Tranchita
Gallant 1968 84 4 9 -18 Miller
Ling 1983 82 4 11 -2 Miller
Powell 1985 174 3 11 . 2 -22 Miller
Johnsen 1987 21 4 12 . 2 -24 Miller
Dahlgren 1989 200 3 13 ** -26 Miller
Johnsen 1992 76 4 13 -26 Miller
CES -  -7
Swinson 1971 60
Metronidazole
4 13 26 Miller
M em ' 1968 24 4 6 -1 -6 Miller
Miller 1968 40 4 6 -6 Miller
T yndel 1969 46 3 7 -I -7 Miller
Gallant 1968 78 4 9 >1 -9 Miller
Lal 1969 71 4 9 -9 Miller
Linton 1967 32 4 10 -1 -10 Miller
Penick 1969 50 3 I I -I -11 Miller
Platz 1970 169 3 10 . 2 -20 Miller
Lowenstam 1969 100 4 12 . 2 -24 Miller
Egan 1968 34 4 13 . 2 -26 Miller
CES = -102
Calcium carbimide
Levy-
Boland
1967
1978
30
50
4
4
8
12
-1 -8
-24
Miller
Miller
CES = -32
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was found by this author. The lack o f  interest in studying antidisotropic medications is 
likely due to the pattern o f  poor outcomes summarized in Table 8. The only controlled 
studies o f  calcium carbimide (N = 2) found negative results. O f the 11 studies o f  
metronidazole, only one found a positive result. Finally, out o f  22 studies o f  disulfiram, 
10 found positive results and 12 found negative results, or less than 50% o f  available 
studies. Based on this review, the results o f  studies o f  antidisotropic medication is mixed 
at best for disulfiram, and there is no reasonable support for metronidazole.
In a similar vein, aversion therapies have literally ceased to be studied since the 
time o f  the Miller et al review. Table 12 shows no new studies were found that met 
criteria for inclusion in this review, the most recent being published in 1991. This again 
may be the result o f  weak research support as only two studies with positive results have 
been published since the end o f  the 1970s. Both covert sensitization and apomorphine 
have positive cumulative evidence scores. However, this is mainly due to studies finding 
positive results tending to have stronger research designs. At best, only half o f  the 
studies have positive results.
Table 13 shows all codings for studies o f  marital and family therapy that have 
shown mixed results. The type o f  therapy that may be most helpful is unclear, as many 
o f  these studies have been a nonspecified, or nonbehavioral format. More clearly defined 
cognitive-behavioral marital and family therapies showed some promise in early studies. 
However, no studies o f  cognitive-behavioral marital or family therapy meeting inclusion 
criteria were found since the Miller review was completed.
Table 14 is a listing o f  studies o f  “standard” treatment components such as milieu 
therapy, general alcoholism counseling, educational lectures, AA, and standard treatment
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Studies o f  Aversion Therapies
Table 12
Author Year n size Severity M QS OLS Product
Review
author
Nausea Apomorphine
Cannon 1981 21 4 14 2 28 Miller
Smith 1991 498 4 to 2 20 Miller
Boland 1978 50 4 12 1 12 Miller
Jackson 1978 344 4 6 -1 -6 Miller
Wallerstein 1957 178 4 9 -I -9 Milter
Richard 1983 112 3 I I -1 -11 Miller
CES -  34
Coven sensitization
Maletsky 1974 20 3 13 2 26 Miller
Ashem 1968 27 4 11 2 22 Miller
Olson 1981 137 4 11 2 22 Miller
Fleiger 1973 32 3 6 -6 Miller
Hedberg 1974 57 4 11 -I - I I Miller
Richard 1983 112 3 11 - I - 11 Miller
Sanchez-Craig 1982 90 4 12 -I -12 Miller
Telch 1984 29 3 12 -12 Miller
CES -  18
Electrical
Marian 1973 65 4 15 2 30 Miller
Caddy 1976 63 4 12 2 24 Miller
Glover 1977 48 4 11 2 V> Miller
Schaefer 1972 26 3 10 2 20 Miller
Vogler 1975 67 4 10 2 20 Miller
Vogler 1970 73 4 5 2 10 Miller
Jackson 1978 344 4 6 -6 Miller
McCance 1969 76 4 12 - I -12 Miller
Vogler 1977 39 4 12 - I -12 Miller
Vogler 1977 119 3 12 -12 Miller
Miller 1978 65 3 15 -15 Miller
Miller 1973 30 4 10 . 2 -20 Miller
Hedberg 1974 57 4 11 . 2 -22 Miller
Regester 1971 62 3 12 •2 -24 Miller
Cannon
CES -  -25
1981 21 4 14 . 2 -28 Miller
Apneic
Laverty 1966 45 3 10 2 20 Miller
Clancy 1967 42 4 10 . 2 -20 Miller
CES = 0
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Studies o f Marital and Family Therapy
Table 13
Review
Author Year n size Severity MQS OLS Product author
Marital/family therapy, cognitive-behavioral
Bowers 1990 16 3 15 1 15 Miller
O'Farrell 1985 36 4 15 I 15 Miller
Hedberg 1974 57 4 11 1 I I Miller
Monti 1990 69 4 11 -1 - I I Miller
McCrady 1986 53 3 15 -1 -15 Miller
CES = 15
Marital/family therapy, nonbehavioral
Cadogan 1973 40 4 13 2 26 Miller
Maharajh 1993 60 4 12 24 Tranchita
Corder 1972 40 4 9 2 18 Miller
Dahlgren 1989 200 3 13 l 13 Miller
McCrady 1979 33 4 10 -1 -10 Miller
Fichter 1993 100 4 14 -1 -14 Tranchita
McCrady 1986 53 _•» 15 -1 -15 Miller
Keso 1990 117 4 12 -24 Miller
O'Farrell
C E S " -12
1985 36 4 15 . 2 -30 Miller
that could not be better specified into another modality have generally continued to 
receive very little support, despite a large number o f  studies that have been completed.
Certain “broad spectrum” skills training approaches to treatment were grouped 
together and displayed in Table 15, as they are focused on various life skills-training and 
not necessarily on alcohol consumption. The basic assumption behind these approaches 
is usually that the individual lacks some skills that would help to keep them sober and 
enhance general life success (Miller et al., 1995).
In this area, we find several promising approaches to treating alcohol problems, 
and several that seem to generally not work very well. For instance, there is a growing 
body o f  evidence that relaxation training, by itself, does not seem to make significant
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Studies o f Standard Treatment Components
Table 14
Author Year n size Severity M Q S OLS Product
Review-
author
Walsh 1991 227
Milieu therapy
2 14 2 28 Miller
Wanberg 1974 180 ■» 10 2 20 Miller
Lal 1969 71 4 9 2 18 Miller
Annis 1979 70 4 8 -1 -8 Miller
Stein 1975 58 4 11 - I l Miller
McLachlan 1982 100 4 12 -12 Miller
Longabaugh 1983 174 3 14 -14 Miller
Edwards 1967 40 4 16 -1 -16 Miller
Eriksen 1986 21 4 9 . 2 -18 Miller
Chapman 1988 105 4 14 •2 -28 Miller
CES = -41
Standard treatment, not otherwise specified
Mosher 1975 200 4 11 - I -11 Miller
Salzberg 1983 2194 7 . 2 -14 Miller
Azrin
CES -  -53
1976 18 3 14 >2 -28 Miller
Alcoholics Anonymous
McCrady 1999 90 3 11 - I -11 Tranchita
Ditman 1967 301 3 12 . 2 -24 Miller
Brandsma 1980 116 4 14 «2 -28 Miller
CES -  -63
General alcoholism counseling
Chick 1988 152 3 16 2 32 Miller
McLatchie 1988 177 6 -6 Miller
Mindlin 1965 232 3 7 - I -7 Miller
Braunstein 1983 174 4 ,  0 -10 Miller
Powell 19885 174 11 -11 Miller
Annis 1992 53 12 -1 -12 Miller
Ogborne 1979 38 4 6 _2 -12 Miller
Pittman 1972 250 4 12 -1 -12 Miller
Caddy 1984 60 3 13 - I -13 Miller
Fitzgerald 1985 332 4 14 - I -14 Miller
Gallant 1968 84 4 9 . 2 -18 Miller
Ditman 1967 301 3 12 . 2 -24 Miller
Oei 1982 32 4 12 -2 -24 M iller
Baldwin 1991 78 4 13 . 2 -26 M iller
Chapman 1988 105 4 14 . 2 -28 M iller
Edwards 1977 100 3 15 . 2 -30 M iller
CES =  -215
(table continues)
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Author Year n  size Severity M QS OLS Product
Review
author
Educational lectures and films
Malfetti 1975 1000 2 9 2 18 Miller
McGuire 1978 1000 2 7 2 14 Miller
Salzberg 1983 2194 2 7 1 7 Miller
Mindlin 1965 232 3 7 - I -7 Miller
Rosenberg 1979 75 4 9 -1 -9 Miller
Swenson 1981 351 2 9 - I -9 Miller
Swenson 1980 436 2 9 -9 Miller
Scoles 1977 122 2 5 . 2 -10 Miller
Baer 1992 132 2 11 -1 -11 Tranchita
Carpenter 1985 30 2 11 - l -11 Miller
Connors 1986 67 2 12 - I -12 Miller
Hagen 1978 8275 2 6 -2 -12 Miller
West 1979 84 4 12 - I -12 Miller
Baker 1975 40 4 14 -1 -14 Miller
Heather 1986 247 3 10 . 2 -20 Miller
Kivlahan 1990 50 1 10 . 2 -20 Miller
Sisson 1986 12 1 12 . 2 -24 Miller
Wells-Parker 1988 3431 2 12 _2 -24 Miller
Burge 1997 242 2 13 . 2 -26 Tranchita
Heather 1990 107 13 . 2 -26 Miller
Brown
CES -  -247
1980 60 2 15 /■> -30 Miller
changes in drinking behavior. However, studies o f  social skills training have had 
generally positive results, as have studies o f  community reinforcement. In fact these two  
modalities are ranked in the top five modalities in terms o f  their CES as obtained in this 
review. Surprisingly, little study o f  these two modalities has been undertaken in the last 
10 years (only one study o f  community reinforcement, none o f  social skills training in 
current review).
Sixteen studies o f  social skills training have been conducted to date, 11 o f  which 
found positive results. Importantly, the mean severity rating across these studies was 
3 . 75, indicating that social skills training may work with fairly severe patients (i. e., those 
diagnosable with severe alcohol dependence).
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Table 15
Studies o f  Broad Spectrum Skill Training
Author Year n size Seven ty MQS OLS Product
Review
author
Social skills training
Azrin 1982 43 4 14 28 Miller
Chaney 1978 50 4 14 28 Miller
Eriksen 1986 24 4 13 2 26 Miller
West 1979 84 4 12 2 24 Miller
Jones 1982 74 4 10 2 20 Miller
Rohsenow 1985 40 10 2 20 Miller
Freed berg 1978 101 4 8 2 16 Miller
Oei 1980 32 4 7 2 14 Miller
Oei 1982 32 4 12 7 12 Miller
Ferrell 1981 22 4 11 i 11 Miller
Monti 1990 69 4 11 i 11 Miller
Jackson 1978 24 4 6 _2 -12 Miller
Cooney 1991 113 4 14
-7 -14 Miller
M iller' 1981 — 2 16 - l -16 Miller
Ends 1957 96 4 10 .  2 -20 Miller
Ferrell 1981 22 4 11 -2 -22 Miller
CES -  126
Community reinforcement
Smith 1998 106 4 16 J, 32 Tranchita
Azrin 1982 43 4 14 28 Miller
Hunt 1973 16 4 13 2 26 Miller
Azrin 1976 18 3 14
7 14 Miller
Sisson 1986 12 1 12 i 12 Miller
CES = 112
Relaxation training
Steffen 1975 4 12 24 Milter
Rohsenow 1985 40 2 10 2 20 Milter
Rosenberg 1979 75 4 9 T 9 Miller
Blake 1967 62 9 -i -9 Miller
Sisson 1981 30 4 0 -9 Milter
Drummond 1994 36 4 10 - i -10 Tranchita
Freed berg 1978 80 4 10 - i -10 Miller
Marlatt 1977 44 I 5 .  2 -10 Miller
Connors 1986 67 ■> 12 - I -12 Miller
Skutle 1987 48 3 14 - I -14 Miller
Miller 1980 45 2 16 -16 Milter
Miller 1980 48 3 16 -16 Milter
Brown 1997 35 J 10 -2 -20 Tranchita
Murphy 1986 46 7 10 _2 -20 Miller
Monti 1990 69 4 11 . 2 -22 Miller
Telch 1984 29 3 12 •2 -24 Miller
CES = -139
Systemic desensitization
Lanyon 1972 21 4 12 2 24 Miller
Hedberg
CES = 13
1974 57 4 11 - l - I t Miller
Problem solving
Sanchez-Craig 1982 90 4 12 -1 -12 Miller
C E S ” -12
O f five studies o f  the community reinforcement approach, all found positive 
results. The mean severity rating is only 3. 2. However, one o f  these studies (Sisson,
1986) had a severity rating o f  1, lowering the mean significantly. Excluding this 
particular study, the mean severity for the other four studies is 3 . 75, indicating that this 
intervention seems to work with samples diagnosable with severe dependence. In fact, 
the Smith (1998) study found positive results in a sample o f  homeless men diagnosable 
with moderate to severe alcohol dependence.
Interventions that fall into the cognitive-behavioral realm have received a great 
deal o f  research attention over the years, and to date have been generally been recognized 
by most experts as effective. However, the evidence presented in Table 16 shows that 
the outcome picture is more mixed than may be appreciated.
Studies o f  behavior contracting and cue exposure are the only two modalities that 
have generally positive findings (i. e„ have a positive CES). O f four studies o f  behavior 
contracting, all found positive studies. Interestingly, no recent studies o f  behavior 
contracting were found for the current review, and the last study was published in 1984.
It is unclear why this apparently promising modality has received so little research
attention.
A very recent but generally positive pattern o f  outcomes has emerged for cue 
exposure therapy. Four studies o f  cue exposure were found for the current review, all o f  
which were published since the time o f  the Miller review. Three had statistically 
significant positive results, indicating that cue exposure may be useful for making 
changes in drinking behavior. While there are four studies, more research should be 
undertaken before making strong conclusions about cue exposure.
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Studies o f  Cognitive-Behavioral Approaches
Table 16
Author Year n size Severity M Q S OLS Product
Review
author
Behavior contracting
Ahles 1983 50 3 13 26 Miller
M iller 1975 20 4 I I 2 22 Miller
Keane 1984 25 4 13 1 13 Miller
Gerrein 1973 121 4 6 2 12 Miller
CES “ 73
Cue exposure
Monti 1993 40 4 13 26 Tranchita
Sitharthan 1997 52 3 11
i
I I Tranchita
Drummond 1994 36 4 10 i 10 Tranchita
Heather 1999 108 3 12 -i -12 Tranchita
CES " 3 5
Self-help manuals
Miller 1978 65 3 15 30 Miller
Miller 1981 35 3 13
T 13 Miller
Reynolds 1995 78 -> 8 -i 08 Tranchita
Guydish 1987 46 3 10 -10 Miller
Baer 19892 132 2 11 -11 Tranchita
Fichter 1993 100 4 14 -14 Tranchita
CES - 0
Cognitive or general cognitive-behavioral therapy
Brandsma 1980 116 4 14 28 Miller
Sitharthan 1996 166 3 13 26 Tranchita
Oei 1982 32 4 12 24 Miller
Oei 1984 18 3 I I 2 22 Miller
Kelley 2000 32 3 10 2 20 Tranchita
Brown 1997 35 3 10
7
10 Tranchita
Rosenberg 1986 22
2
8 - i -8 Miller
Ito 1988 48 4 I I - i -11 Miller
Jackson 1978 24 4 6 .  2 -12 Miller
Rice 1993 3 12 -1 -12 Tranchita
Ojehagen 1992 72 3 16 • I -16 Tranchita
Project M A TC H 1996 1726 3 16 - I -16 Tranchita
Monti 1990 69 4 11 . 2 .  22 Miller
Sandahl 1998 59 4 11 .  2 -22 Tranchita
Sitharthan 1997 52 3 11 .  2 . 22 Tranchita
CES = -1 1
(table continues)
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Author Year n size Severity MQS OLS Product
Review
author
Behavioral self-control training
Harris 1990 34 3 16 2 32 Miller
Brown 1980 60 2 15 2 30 M iller
Alden 1988 144 2 14 2 28 M iller
Baker 1975 40 4 14 2 28 Miller
Sobell 1973 70 4 14 2 28 Miller
Caddy 1976 63 4 12 2 24 Miller
Hester 1997 40 2 10 2 20 Tranchita
Lo vi bond 1975 58 2 10 2 20 Miller
Miller 1980 45 2 16
T 16 Miller
Robertson 1986 37 3 14 i 14 Miller
Sandahl 1990 53 4 7 2 14 Miller
Baldwin 1991 78 4 13
T 13 M iller
Heather 1990 107 3 13 i 13 Miller
Coghlan
Heather
1979
1986
60
247
3
3
10
10
i
i
10
10
Miller
M iller
Guydish 1987 46 10 - I -10 Miller
Carpenter 1985 30 2 11 1 -11 Miller
Heather 1999 108 3 12 -1 -12 Tranchita
Vogler 1977 119 3 12 -I -12 Miller
Miller 1981 35 3 13 -1 -13 Miller
Pomerleau 1978 32 14 -14 Miller
Sanchez-Craig 1989 90 14 •1 -14 Miller
Skutle 1987 48 14 -I -14 Miller
Miller 1978 65 15 -1 -15 Miller
Sanchez-Craig 1991 96 3 15 -15 Miller
Sanchez-Craig 1984 70 3 15 -1 -15 Miller
Miller 1980 48 16 -16 Miller
Collins 1996 72 9 . 2 -18 Tranchita
Kivlahan 1990 50 1 10 -20 Miller
Connors 1992 63 2 14 . 2 -28 Miller
Sannibalc 1988 96 3 14 -2 -28 Miller
Heather 1987 104 2 15 -2 -30 Miller
For­
c e s - -17
1984 62 4 16 -2 -32 Miller
Relapse prevention
O'Farrell 1993 59 4 15 2 30 Miller
Chancy 1978 50 4 14 2 28 Miller
Caddy' 1984 60 J 13 2 26 Miller
Cisler 1998 37 3 8 - I -8 Tranchita
Rosenberg 1986 22 2 8 -8 Miller
McCrady 1999 90 3 11 -11 Tranchita
Annis 1992 56 3 12 - I -12 Miller
O'Malley 1996 104 3 12 - I -12 Tranchita
Skkutle 1987 48 3 14 -1 -14 Miller
Allsop 1997 60 4 12 «2 -24 Tranchita
Obelensky 1984 96 2 13 «2 -26 Miller
C E S --3 1
Functional analysis
Coghlan 1979 60
Connors 1986 67 2
Rice 1993 229 3
CES = -34
10 -1 -10 Miller
,  2 -1 -12 Miller
12 - I -12 Tranchita
(table continues)
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Author Year n size Severity’ MQS OLS Product
Review
author
Self-monitoring
Eriksen 1986 21 4 9 I 9 Miller
Harris 1990 34 3 16 -2 -32 Miller
CES -  -23
BAC discrimination training
Volger 1977 119 3 12 -1 -12 Miller
Volger 1977 39 4 12 -I -12 Miller
CES = -24
Contingency management
Cox
CES = 2 0
1998 298 4 13 2 26 Tranchita
Functional analysis has failed to obtain statistically significant changes in 
drinking behavior across three studies. While three studies is a limited number to be 
making strong conclusions, there is as yet little reason to believe it is effective for 
making significant changes in drinking behavior.
It is difficult to make any concrete conclusions about the remaining cognitive- 
behavioral treatment modalities (relapse prevention, behavioral self-control training, self- 
help manuals, and cognitive-behavioral therapy not otherwise specified). Studies o f  
these modalities has produced mixed results: about one third o f  studies focusing on these 
four modalities obtained positive results (26 o f  75). Interestingly, relapse prevention 
studies have shown a significant change in the pattern o f  outcomes from the time o f  the 
Miller et al review. Formerly, relapse prevention had a positive CES o f  34. Research 
since that time has generally obtained negative results, reducing the CES significantly 
(by 65). It is unclear at this time why more recent studies have generally found negative
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results. At this time, only 3 o f  11 studies o f  relapse prevention for alcohol use have 
obtained positive results, and ail four recent studies obtained by the present author had 
negative results, indicating again that more recent research into this modality has not 
proven it very effective in changing drinking behavior.
While these four modalities all have zero or negative cumulative evidence scores, 
it is difficult to ignore the 26 studies that found positive results, particularly the 15 
positive results for behavioral self-control training. While it is beyond the scope o f  this 
review, perhaps future researchers might study characteristics o f  people for whom these
interventions seem to work or not work.
Studies o f  other psychotheapeutic approaches that are not cognitive or cognitive- 
behavioral in nature have produced mixed results (see Table 17). For example, insight- 
oriented psychotherapy alone has generally not been found to have significant impacts on 
measures o f  drinking. Client-centered therapy seems to have somewhat more promising 
findings, though the results are quite mixed.
As can be seen in Table 18, little study o f  confrontational approaches has been 
conducted since the time o f  the Miller review, likely due to the very limited positive 
results reported. O f all available studies reviewed, there was not one demonstrating a 
statistically significant positive impact on drinking.
Table 19 lists all studies coded in modalities listed in the “other therapies. ” These 
modalities, with the exceptions o f  hypnosis and acupuncture, have not received sufficient 
research attention to allow for conclusions. None o f  the four studies o f  hypnosis 
included in this review found positive results, indicating that hypnosis alone does not 
impact alcohol abuse. For acupuncture, only one o f  the three studies included in this
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Studies o f  Psychotherapy
Table 17
Author Year n size Severity M QS OLS Product
Review
author
Ends 1957 96
Client centered
4 10 2 20 Miller
Telch 1984 29 3 12 1 12 Miller
Valiev 1981 247 4 11 1 11 Miller
Rosenberg 1986 22 2 8 -1 -8 Miller
O ’Malley 1996 104 3 12 -1 -12 Tranchita
C E S - 2 3
Insight-oriented psychotherapy
Rhead
Sandahl
1977
1998
103
59
4
4
11
11
2
1
22
11
Miller
Tranchita
Johnson 1970 95 3 9 -9 Miller
Bruun 1963 303 3 11 -I -11 Miller
Jacobson 1973 80 3 11 -1 -11 Miller
Zimberg 1974 113 11 - I - 11 Miller
Ludwig 1969 176 4 13 -13 Miller
Ojehagen 1992 72 16 -I -16 Tranchita
Swenson 1981 351 9 . 2 -18 Miller
Olson 1981 137 4 11 -2 -22 Miller
Wells-Parker 1988 3431 *> 12 . 2 -24 Miller
Bowers 1990 16 3 15 .  2 -30 Miller
C E S - -132
Developmental counseling
Alden 1988 144 14 2 28 Miller
CES -  28
review found positive results. It is difficult to reach any conclusions based on so few
studies, though it is important to note that the tw o most recent studies found did not find
positive results.
Trend o f  Methodological Quality
The following analysis is presented to answer the research Question 4: Has the
quality o f  research methodology improved over time?
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Studies of Confrontational Approaches
Table 18
Review
Author Year n size Severity MQS OLS Product author
Fain 1976
Videotape self-confrontation
46 4 4 -1 -4 Miller
Schaefer 1971 52 4 11 -1 -11 Miller
Volger 1977 119 3 12 -I -12 Miller
Vogler 1977 39 4 12 -1 -12 Miller
Baker 1975 40 4 14 - I -14 Miller
Lanyon 1972 21 4 12 . 2 -24 Miller
CES -  -77
Confrontational counseling
Swenson 1980 436 2 9 -1 -9 Miller
Ino 2000 278 3 5 .  2 -10 Tranchita
Bjornevoll 1972 35 4 11 -1 -11 Miller
Pomerleau 1978 32 3 14 -1 -14 Miller
Miller 1990 30 2 15 -1 -15 Miller
Miller 1973 30 4 10 . 2 -20 Miller
Annis 1983 150 -> 14 . 2 -28 Miller
Sannibale 1988 96 14 .  2 -28 Miller
CES = -135
First, an analysis o f  variance was conducted to determine if there were significant 
differences between mean methodological quality by decade. Due to the small number o f  
studies conducted in the 1950s (eight), these were collapsed in with the studies from the 
1960s. For the same reason, studies for the year 2000, (13) and 2001 (one) were 
collapsed in to the 1990s category. Table 20 is a listing o f  the number o f  studies, mean 
methodological quality and standard deviation by decade. Looking at this table w e can 
see the mean methodological quality score has generally increased by decade, except 
between the 1980s and 1990s (including studies from 2000 and 2001).
Table 21 is the analysis o f  variance table conducted to determine if  there are 
statistically significant differences between the mean methodological scores across
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Studies o f  Other Therapies
Table 19
Author Year n size Severity MQS OLS Product
Review
author
Bullock 1987 54
Acupuncture
4 10 2 20 Miller
Sapir-Weise 1999 72 12 -1 -12 Tranchita
Worner 1992 56 3 8 _2 -16 Tranchita
CES = -8
Edwards 1966 40
Hypnosis
4 8 -1 -8 Miller
Wallerstein 1957 178 4 9 -1 -9 Miller
Jacobson 1973 80 3 11 -1 -11 Miller
Ludwig 1969 176 4 13 -1 -13 Miller
C E S - -41
Tobacco cessation treatment
Bobo 1998 575 3 12 2 24 Tranchita
Bobo
CES = 4 4
1995 90 3 10 2 20 Tranchita
Reduced environmental stimulation training (REST)
Cooper 1988 59 1 10 2 20 Miller
Cooper 1988 51 1 10 2 20 Miller
CES - 4 0
E M G  Biofeedback
Taub
C E S - 2 2
1994 250 4 11 22 Tranchita
Transcendental meditation
Taub
CES = 22
1994 250 4 I I 2 22 Tranchita
Contingency management
Petry 2000 42 3 10 2 20 Tranchita
CES -  20
Feedback o f  assessment results
Agostinelli 1995 26 2 10 2 20 Tranchita
CES = 20
Nurse intervention
Patterson
CES = 20
1997 127 3 10 2 20 Tranchita
(table continues)
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Author Year « size Severity MQS OLS Product
Review
author
Detoxification
Bennie
C E S = 12
1998 95 4 12 1 12 Tranchita
Exercise
Murphy 1986 46 1 10 2 20 Miller
Levinson
CES = 9
1969 60 4 11
-T -11 Miller
Occupational therapy
Rice 1993 229 3 12 - i -12 Tranchita
CES = -12
Twelve-step facilitation
Project M A TC H 1996 1726 3 26 - i -16 Tranchita
CES = -16
Kudzu Root
Shebek 2000 49 4 10 -20 Tranchita
CES = -20
Assessment as tested intervention
Richmond
CES = -30
1995 378 15 -50 Tranchita
Neurotherapy
Padjen 1995 67 3 11 -22 Tranchita
Taub 1994 250 4 11 -2 -22 Tranchita
CES = -44
decades. The ANOVA did indicate that there is a statistically significant difference 
between methodological quality scores across decades.
Table 22 is the post-hoc comparisons o f  the mean scores across decades. As can 
be seen in the table, there were statistically significant differences in mean 
methodological quality scores across all decade comparisons except when comparing 
studies published in the 1980s with those published in the 1990s (including 2000 and 
2001). The general trend is for increases in mean methodological quality from decade to
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Summary o f  Methodological Quality Scores by Decade
Table 20
Decade N Mean MQS Standard deviation
1950s and 60s 53 9. 21 2 . 78
1970s 94 10. 67 2. 84
1980s 130 12. 33 2. 36
1990s and 2000s 164 12. 23 2. 22
Total 441 11. 56 2. 69
Table 21
ANOVA o f  MOS by Decade
Group Sum of squares d f Mean square F P
Between 517. 6 **3 172. 5 27. 6 <001
Within 2674. 9 437 6 . 1 -
Total 3192. 5 440 --
Table 22
Tukey Post Hoc Comparisons o f  MOS by Decade
Decade Comparison decade Mean difference Standard error P
1950s and 60s 1970s -1. 46 . 425 . 003
1980s -3 . 12 . 403 < 0 0 1
1990s -3. 02 . 391 < . 001
1970s 2980s -1. 66 . 335 < . 001
1990s -1. 56 . 320 < . 001
1980s 1990s and 2000s 0 . 11 . 291 . 984
67
decade, with the exception from the 1980s to 1990s. This is evidence in support o f  the 
hypothesis that increases in methodological quality scores have indeed occurred over 
time. However, MQS values began to level o f f  starting in the 1980s. This may indicate a 
ceiling effect for improvements in methodological quality, at least as measured by this
system.
A statistically significant zero-order Pearson correlation was found between the 
year the study was published (entered into the correlation as a continuous variable), and 
the methodological quality score (r = .  356, p  <. 001). The r-square value is.  127, 
indicating that study year accounted for 12. 7% o f  the variance in methodological quality
scores.
Figure 1 is a scatter plot with methodological quality scores on the y-axis, and 
study year on the x-axis. Again, we can see the general upward trend in methodological 
quality scores over time.
Variables Predictive o f  Outcome
A regression analysis was planned and discussed in the research questions section 
(under research question 3) with product score as the dependent variable and various 
sample and methodological characteristics as possible predictors. Originally, the goal 
was to determine if  any o f  the sample characteristics o f  the studies included predicted 
outcomes. However, further study o f  the product score variable revealed that this 
analysis was not possible, given the nature o f  the scores. The positive and negative 
values o f  the product scores reflect separate, discontinuous constructs that do not lend 
themselves to a regression analysis.
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year
Figure 1. Regression o f  MQS by year.
A scatter-plot product scores over time is included in Figure 2 to illustrate the two 
distinct groups o f  data points that represent the product scores. The gap between these 
two data points is due to the fact that the product score is, as it sounds, a product o f  two 
variables, MQS and OLS. The minimum MQS was 4, and when multiplied by OLS, 
which can only be -2 , -1 ,  1, or 2, there is necessarily a gap o f  product scores around zero 
(between -4 and 6 to be exact). Therefore, this variable does not lend itself to regression 
analyses.
Given the separate and distinct nature o f  these positive and negative scores, 
separate regressions were considered for positive and negative values. However, it was 
decided that this would only show i f  sample characteristics were predictive o f  the 
methodological quality scores, rather than predictive o f  study outcomes. This analysis
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would not be clinically useful or meaningful. Therefore, this analysis was also
abandoned.
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DISCUSSION
This review was intended as an update o f  Miller et al. (1995) meta-analysis o f  
controlled alcohol treatment outcome studies, using the same coding methodology. The 
database upon which conclusions are based included all 206 studies reviewed by Miller, 
as well as 100 more studies compiled by the present writer, completed since the time o f  
the prior review. Inter-rater reliability for coding the 100 new studies was established 
with a trained undergraduate student judge. Reliability o f  ail coding variables ranged 
from 79 - 100%, with an average o f  87%. These numbers compare favorably to that 
obtained by Miller et al. (1995).
The present review had several purposes: (a) to establish an updated rank ordering 
o f  treatment modalities, comparing/contrasting this with the ranking obtained by Miller 
et al. (1995), (b) to determine if a trend exists over time regarding improved 
methodological quality, and (c) to determine if  certain sample and study characteristics 
are differentially predictive o f  outcome.
Efficacy o f  Psychosocial and Behavioral Treatment Modalities
Brief interventions including motivational interviewing techniques continue to 
show themselves to be effective in reducing the drinking behavior in less severe samples. 
Study samples were usually identified through paper-and-pencil screening instruments 
such as the CAGE or AUDIT, and given short interventions, often less than one hour 
focused on reducing drinking behavior. At follow-up periods between 3 months and 
several years, statistically significant reductions in drinking behavior are generally found
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in large samples o f  people measured both by self-report and objective physiological 
measures. This is a meaningful and important result that could be used to make public 
policy regarding these types o f  interventions for the purpose o f  improving general health 
o f  populations. However, given the less severe samples on which these interventions 
were tested, it would likely be prudent to also make referrals to more stringent treatment 
approaches for more severe drinkers.
It is somewhat difficult to compare the present results to those o f  other meta­
analyses and reviews discussed in the introduction due to the varied nature o f  the 
conclusions o f  those reviews. Furthermore, those reviews utilized a level o f  specificity 
(male vs. female, duration o f  intervention) that is beyond the scope o f  this review, and, 
indeed, is a relative weakness o f  the current review. However, this review is still able to 
point to a general trend in support o f  brief interventions that is important to note.
Other psychosocial treatments that have generally received support with more 
severe samples (i. e., diagnosable with an alcohol misuse disorder) include social skills 
training, community reinforcement, behavior contracting and, more recently, cue 
exposure. Surprisingly, behavior contracting has received very little research attention, 
despite generally positive results. The fact that social skills training is on this list may 
indicate that alcoholics tend to have a number o f  interpersonal deficits that may 
contribute to excessive drinking to alleviate anxiety in social situations. This is further 
supported by the fact that community, which is designed to help drinkers find new ways 
to interact and be reinforced socially, reinforcement has also shown to be effective. The 
fact that cue exposure is shown to be effective in changing drinking behavior may 
indicate that classically conditioned cues play an important role in maintaining drinking
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behavior and relapse. This is a fact that may be overlooked by many clinicians and is not 
addressed experientially by most treatment modalities. As such including some 
assessment and treatment o f  these classically conditioned cues for cravings should be an 
important part o f  any treatment program.
There is also a trend for cognitive-behavioral marital and/or family therapy to be 
helpful in reducing drinking behavior. However, there has been little recent focus on this 
broadly defined group o f  interventions. Relatively, there exists a greater number o f  
nonbehavioral marital and/or family therapy studies, which have generally shown to be 
much less effective than the cognitive-behavioral approaches. Again, it is difficult to 
compare the results o f  this review to others mentioned in the introduction. In the case o f  
family therapy, the Edwards and Steinglass (1995) review grouped outcome o f  studies by 
various time periods o f  treatment (initiation o f  treatment, during treatment, and 
aftercare). The present review did not pursue this due to the inapplicability o f  these 
variables to this review, and to the studies included herein. Furthermore, Edwards and 
Steinglass did not differentiate studies by type o f  family intervention (i. e., behavioral vs. 
nonbehavioral). Therefore, the level o f  specificity was very different across reviews, 
though both that review and the present one found some support for the use o f  marital/ 
family therapy.
Other cognitive-behavioral interventions such as relapse prevention, CBT 
(cognitive-behavioral therapy), behavioral self-control training, and self-help books have 
very mixed results in the current review. For relapse prevention, this is a significant 
change since the Miller et al review, in which they found a positive CES for this 
modality. However, these results are similar to the Carroll (1996) review that only found
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one study in which relapse prevention was superior to another psychosocial treatment. It 
is possible that future patient-treatment-matching studies may find sample characteristics 
that help to predict for whom these cognitive-behavioral interventions are helpful.
Studies o f  insight-oriented psychotherapies have consistently found negative 
results, indicating that this modality is not useful by itself in making significant changes 
in drinking behavior. However, there was some evidence that client-centered therapy 
makes significant changes in som e samples (three out o f  five studies). It may again be 
the case that treatment-matching studies may find sample characteristics predictive o f
treatment outcome.
Other psychosocial and behavioral treatments listed in this review (with sufficient 
studies to make conclusions) have generally not been supported by research evidence. 
Several o f  these modalities have received very little recent research attention such as 
aversion and confrontational approaches.
Other modalities that have generally not been supported by research evidence 
include those labeled as ‘‘Standard Treatment Components'’ in the Miller et al. (1995) 
review. Included in this group are milieu therapy, standard treatment not otherwise 
specified, AA, general alcoholism counseling, and educational lectures and films. With 
the exception o f  AA (for which there were only three studies for this review), these 
modalities have received a great deal o f  research attention, despite the general lack o f  
positive findings for these modalities. This is an important and disturbing result, given 
that these interventions are very commonly used in most clinical settings.
It is difficult to draw any conclusions about AA based on evidence from this 
review. As mentioned in Tonigan, Toscova, and Miller (1996), there is a fairly large
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body o f  literature written about AA; however, the research quality is generally poor and 
includes very few controlled trials (three found in this review). However, this does not 
mean that AA does not work or that it is a poor intervention. Rather, quality outcome 
research on AA is scarce. This fact may speak to the nature o f  AA, which is led by “lay” 
members rather than professional therapists. Furthermore, while there are a standard 12 
steps that AA members follow, meetings are not run in a standardized manner across
communities.
Efficacy o f  Pharmacological Treatments
Research regarding antidisotropic medications such as disulfiram (antabuse) and 
metronidazole has produced mixed results, and such medications have received little 
research attention since the time o f  the Miller et al. review (only one o f  disulfiram in the 
current review). O f 11 studies o f  metronidazaole, 10 found negative results, which 
should prompt an obvious conclusion about this modality. However, o f  22 studies o f  
disulfiram, 10 found positive results—slightly less than half. These mixed results are a 
bit harder to interpret, but are generally negative.
This trend is somewhat disturbing in that disulfiram also continues to be included 
as one o f  the “standard” treatment components by many practitioners. Other reviews o f  
antisotropic medications such as O ’Brien and McKay (1998), Garbutt et al. (1999), and 
Swift (1999), also reached similar conclusions (i. e., “mixed” support for disulfiram). The 
one exception was that O’Brien and McKay concluded that studies o f  disulfiram, when 
used concomitantly with behavior contracting, showed better results. A reservation with 
that particular conclusion is that behavior contracting seems to  work fairly well on its
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own. Therefore, it may have been that behavior contracting largely accounted for the 
behavior change, independent o f  the disulfiram. It appears, generally, that the research 
evidence regarding the use o f  this medication may not support its widespread use. 
However, there may be a need for further research into when this medication may or may 
not be effective. For example, perhaps more effective monitoring o f  the medication
would lead to better results.
There has been an explosion in the number o f  studies examining the efficacy o f  
psychotropic medications for the treatment o f  alcohol misuse since the time o f  Miller's 
review (which covered studies up to 1992). The percentage o f  total codable outcomes 
accounted for by studies o f  psychotropic medications has approximately doubled since 
the time o f  the Miller review (i. e., from 8. 2 - 16. 5% o f  all outcomes included in the 
present review). Indeed, studies o f  psychotropic medications accounted for 37% o f  all 
new studies found by the present author since 1992.
However, the explosion o f  research into psychotropic medications has failed to 
identify medications that are reliably useful in changing drinking behaviors, with the 
possible exception o f  GABA agonists (acamprosate). GABA agonist medication has 
received a great deal o f  support from the controlled studies published since the time o f  
the Miller et ai. (1995) review. Studies in this review all included patients who likely 
meet diagnostic criteria for an alcohol misuse disorder. In line with the present review, 
other recent reviews have consistently concluded that GABA agonist medication is an 
effective means o f  treating alcohol misuse.
Other research into the use o f  psychotropic medications to change drinking 
behavior has reported mixed results. Studies o f  narcotic antagonists (naltrexone,
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nalmefene) and lithium have obtained mixed results, with slightly less than half o f  
studies obtaining positive results (3 out o f  7 studies for both medications). Further, the 
conclusion o f  the present review regarding the lack o f  efficacy o f  lithium for alcohol 
misuse is similar to that o f  other reviews listed in the introduction.
However, the present conclusions regarding naltrexone runs counter to several o f  
the reviews cited, which tended to conclude there is empirical support for its use. This 
discrepancy seems to exist because the current study includes a number o f  articles that 
the others do not, either due to the other studies being somewhat dated, or due to 
different exclusionary criteria. The review o f  O ’Brien and McKay (1998) does not 
include three studies included in the current review (all o f  which had negative results), 
and the conclusions o f  Batel (1995) and Garbutt et al. (1999) both based conclusions on 
only three studies (and not the same three studies). There does appear to be a slight trend 
for more recent studies to be less supportive o f  the use o f  naltrexone, which could 
explain why earlier reviews concluded there was support for the use o f  this medication. 
However, not all o f  these studies were negative, indicating that future research into 
naltrexone could focus more on the question o f  patient-medication matching.
Other psychotropic medications, including antidepressants (e. g., imiprimine), 
selective seratonin reuptake inhibitors (SSRIs; e . g., sertraline), psychedelics (e g., 
lysergic acid [LSD]), dopamine agonists (e  g ., bromocriptine), seratonin antagonists (e . g., 
ritanserin), and antianxiety medication (e. g., buspirone) have generally not proven 
reliably effective over placebo for changing drinking behavior. These conclusions 
generally match those o f  other reviews mentioned in the introduction. However, some o f  
the prior reviews have emphasized that some o f  these medications are more useful when
utilized to treat comorbid disorders (e. g., depression, anxiety, etc. ). Studies focusing on 
treatment o f  comorbid diagnoses have not been included in the present review, and 
therefore, no conclusions regarding this assertion were reached in this review.
Trends in Methodological Quality
With regard to methodological quality, a definite trend was found in this body o f  
literature for improved quality o f  research, though this trend seem s to have flattened out 
since the 1980s. A  statistically significant correlation was found between the year 
studies were published and methodological quality score (M QS), accounting for about 
12% o f  total variance in MQS.
Furthermore, there were statistically significant increases in mean MQS from 
decade to decade (until the 1990s when the mean MQS was almost the same as that seen 
in the 1980s). It is unclear whether this should be viewed as a plateau, and that w e can 
expect mean MQS to continue to improve in the coming decades, if it is a "ceiling effect” 
(that methodological quality is not likely to improve much more), or if  it is evidence that 
research is improving in ways that are not measured in this meta-analysis. The last o f  
these options seems most likely, and future reviews should begin to take other 
methodological variables into account.
Variables Predictive o f  Outcome
A planned regression analysis to determine which, if  any, sample and study 
characteristics helped to predict product scores was abandoned due to the nature o f  the 
product score variable. Product scores are separated into tw o separate clusters for studies
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with positive versus negative results, and, therefore, regression analysis would likely not 
be useful for this variable.
Individual treatment modalities were examined to determine if  certain variables 
were important to explain the pattern o f  results. In this review it was difficult to make 
many conclusions regarding these variables, and no real conclusions could be made 
regarding certain variables being predictive outcome.
However, there were several areas where sample characteristics were important to 
making conclusions regarding the efficacy o f  certain treatments. Specifically, brief 
interventions and motivational enhancement were all tested on less severe populations, 
and, therefore, conclusions can only be made regarding using these therapies for less 
severe populations. In contrast, studies o f  GABA agonists (acamprosate), social skills 
training, and community reinforcement gave evidence for efficacy o f  these modalities 
with more severe populations that likely meet diagnostic criteria for an alcohol misuse 
disorder. While sample severity is not considered predictive o f  these outcomes, it gives 
further explanation o f  the results.
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Clinical Implications
It is important to qualify what can, indeed, be concluded from this review in 
regards to clinical decision-making. This review is purposely limited in scope to trials 
with control or comparison groups, and focused on finding studies that have made 
statistically significant differences on measures o f  drinking in samples o f  people who 
generally do not have other comorbid diagnosable substance misuse disorders. 
Therefore, the conclusions o f  this study should be applied only to such populations.
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Also, conclusions should be tempered by the realization that there is a large body o f  
uncontrolled studies o f  these modalities that did not meet inclusion criteria for this 
review. However, it is generally recognized that controlled studies are the strongest 
design for making conclusions about efficacy, and, therefore, some conclusions can be 
made regarding the efficacy o f  these treatments based on this review.
People in a role o f  seeing large numbers o f  people where alcohol screening would 
be feasible such as a general medical practice, emergency room, or even a large-scale 
employer would likely be justified in deciding to utilize brief interventions. This review, 
along with others, has shown that these interventions have generally proven effective in 
making significant changes in less severe drinkers. Therefore, from a public health 
perspective, these interventions could be very helpful in reducing drinking behavior in 
large groups o f  people who may not be diagnosable with an alcohol misuse disorder, but 
are drinking at a level that may have a negative impact on their long-term health.
Those making decisions regarding more severe populations o f  drinkers have a 
range o f  interventions enjoying research support based on this review. Interventions that 
could be tentatively suggested based on this review include: GABA agonist medication, 
social skills training, community reinforcement, behavior contracting, cue exposure, and 
possibly cognitive-behavioral marital and/or family therapy. This does not mean that 
other treatment approaches may not be useful. In many cases, it means that study results
are mixed, and that further and different research is needed.
A list o f  empirically supported treatments could provide clinicians with a “menu” 
to choose from. Clinicians often do not use single modality interventions, but rather a 
combination o f  several. Having a list o f  several modalities that are empirically supported
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means that a clinician could make a number o f  them available for use with clients, and 
attempt to meet individual client needs through informed judgments o f  combinations o f  
treatments. Furthermore, clinicians could then easily shift to another empirically 
validated modality, if  necessary.
Perhaps what the present review can best emphasize are treatments that have 
generally not been supported by research, and perhaps should be avoided or abandoned 
This list includes a number o f  treatment modalities that are generally considered 
“standard” treatment components that are commonly utilized such as milieu therapy, 
general alcoholism counseling, and educational lectures and films. Other commonly 
used treatment modalities that have received very little controlled research support 
include insight-oriented psychotherapy and confrontational approaches
Implications for Research
Methodological quality o f  the alcohol treatment outcome research, as measured 
by Miller et al. (1995) meta-analysis, has made significant improvements over time. This 
is a heartening trend that hopefully will continue.
Along with being a means o f  making some clinical decisions, it is hoped that this 
review will be utilized as a guide for future research. There are some modalities in this 
review that have received generally positive results, but have been researched relatively 
little, such as behavior contracting and cue exposure, while other modalities have 
received a great deal o f  research attention, but have generally not been supported such as 
educational lectures and films. Knowledge such as this could be utilized in making
decisions about what modalities could benefit the most from research attention.
Other research decisions could be made in terms o f  changing research goals. 
Specifically, modalities for which research is mixed such as some o f  the cognitive- 
behavioral interventions (relapse prevention, behavioral self-control training, self-help 
books, behavioral marital and family techniques), disulfiram (Antabuse), narcotic 
antagonists (Naltrexone, Nalmefene), client-centered psychotherapy, and aversion 
techniques may be most benefited with research into matching treatment to patient 
characteristics. The controlled research into these modalities seems to show that they 
work some, but not all, o f  the time. Further study into matching these types o f  treatments 
to patients may help clinicians to understand when these treatments will be most 
beneficial. Some examples o f  possible patient variables that may be significant treatment 
predictors would be level o f  education, comorbid diagnoses (depression, anxiety, 
antisocial personality disorder), amount o f  drinking at time o f  intake into treatment, and 
past treatment history.
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Limitations and Future Directions
Some o f  the limitations o f  this review are fairly obvious, and can and should be
addressed in future reviews.
First, other than the corrections listed earlier, the current empirical data reported 
herein relies in part on the accuracy o f  reported scores in the Miller et al. review. The 
few  numerical mistakes noted by this author in the Miller et al. review are unlikely to 
have much o f  an impact on the overall conclusions o f  a review o f  this nature given the 
robustness o f  the findings (i. e., large number o f  studies utilized). However, a future
review could perhaps reassess the accuracy o f  these codings to  ensure that conclusions 
are based on as reliable data as possible.
Other limitations involve the scoring system utilized for this review. The 
outcome logic score calculation is, in som e ways, fairly arbitrary, and causes a loss o f  a 
great deal o f  data. For example, studies with the same methodology that find no 
improvement at all, or even deterioration on drinking measures, get the same OLS as a 
study that finds improvements on drinking scores that were not statistically significant. 
While it is difficult to draw conclusions about improvements that are not statistically 
significant, these two results make very different statements about the use and utility o f  
the given treatment modality. Future reviews that utilize actual treatment effect sizes 
would be helpful.
Furthermore, data are lost when each modality is assigned one outcome score per 
sample. Many studies will have several outcome measures that may be considered 
important. For example, a study may report a self-report measure o f  drinking, an 
objective physiological measure o f  alcohol use such as breathalyzer, M CV, or GGT, an 
objective measure o f  functioning such as hospitalization rates, and other measures o f  
psychosocial functioning such as a measure o f  depression. All o f  this data may be 
important to determine if the intervention made a meaningful difference in the 
functioning o f  the person being treated, and is, in many cases, contradictory. With the 
current methodology, a judgment call was necessary to determine which o f  the reported 
results was the best measure o f  whether the intervention made a statistically significant 
difference in drinking, and completely ignored measures that were not measures o f  
drinking. Perhaps future reviews could focus on determining effects o f  specific
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modalities on several measures by computing effect sizes for each o f  the outcome 
measures, including other psychosocial measures.
The “Take Home” Message
There are several important points that a reader can glean from this review.
First, it is important to emphasize that methodological quality o f  alcohol treatment 
research has, indeed, improved over time. This trend toward seems to have reached a 
plateau over the past 10 years.
Second, controlled research points the clinician to a number o f  treatments that 
seem to be efficacious for treatment o f  severe alcohol misusers. Those identified by this 
review include: GABA agonist medication, social skills training, community 
reinforcement, behavior contracting, and cue exposure. Combinations o f  these 
treatments could be utilized by clinicians to address the needs and symptoms o f  
individual patients.
Third, brief interventions, including motivational enhancement, have consistently 
proven to be an effective means o f  changing drinking behavior across large groups o f  
people with less severe alcohol problems (i. e., do not meet criteria for an alcohol misuse 
disorder).
Fourth, there are a number o f  treatment modalities still regularly utilized by 
clinicians that have consistently been shown in controlled research to have little or no 
impact on alcohol use (including milieu therapy, general alcoholism counseling, 
educational lectures and/or films, and confrontational counseling).
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Lastly, there are a number o f  treatment modalities for which the research is mixed 
such as a number o f  cognitive-behavioral techniques (i. e., relapse prevention, behavioral 
self-control training, self-help books, and behavioral marital and family therapy), client- 
centered therapy, disulfiram (antabuse), aversion techniques, and narcotic antagonist 
medication (Naltrexone). Outcome research has shown these treatments to be effective 
in some studies, but ineffective in others. Further research should be undertaken that 
could further study for whom these therapies are helpful (i. e., “matching” patients to
treatment).
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Appendix A: Coding Manual from Miller et al. 
Megatable Coding Manual
TREATMENT MODALITY CODES
1. AA Alcoholics Anonymous
2. AC Acupuncture
3. AM Antidipsotropic Medication
4. AMcc Calcium Carbimide
5. AMdi Disulfiram
6. AMme Metronidazole
7. AS Assessment as tested intervention
8. AV Aversion Therapy
9. AVap Apneic
10. AVcs Covert Sensitization
11. Avel Electrical
12. AVna Nausea - apomorphine
13. AVne Nausea - emetine
14. AVnl Nausea - lithium
15. AVnm Nausea - motion sickness
16. BA BAC Discrimination Training (by internal cue feedback)
17. BC Behavior Contracting
18. BE Behavioral Self-Control Training
19. BF Biofeedback
20. BFee EEG biofeedback (alpha/theta, etc.)
21. BFem EMG
22. BI Brief Intervention (advice)
23. CE Cue Exposure
24. CG Counseling - General Alcoholism
25. CH Client Choice among options
26. CM Case management
27. CN Confrontational Counseling
28. CNji Johnson Institute Intervention
29. CR Community Reinforcement Approach
30. CT Cognitive Therapy (including cognitively-based relapse prev)
31. DC Developmental Counseling (Egan)
32. DT Detoxification
33. ED Education (in person lectures, films, etc.; not reading)
34. EDd Disease-model education
35. EDI Learning theory education
36. EX Exercise program (e.g ., aerobic)
37. FA Functional Analysis
38. FB Feedback o f  assessment results
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39. FT Family Therapy (not marital therapy)
40. FTcb Cognitive-Behavioral family therapy
41. FTfs Family Systems/Structural
42. FTo Family Therapy, other or unspecified orientation
43. FTun Unilateral Family (or Marital) Therapy (behavioral skills training)
44. HO Housing provided as part o f  treatment
45. HOac Housing contingent upon abstinence (not residential treatment 
setting)
46. HOnc Housing noncontingent (not residential treatment setting)
47. HY Hypnosis
48. JT Job-finding or job-skill training (specifically; do not code with OT)
49. ME Motivational Enhancement or Motivational Interviewing
50. MI Milieu Therapy (include therapeutic community)
51. MM Minnesota Model
52. MO Self-Monitoring
53. MP Medical Procedure (e g ., surgical - not medication)
54. MT Marital
55. MTcb Cognitive/Behavioral Marital Therapy
56. MTss Marital Therapy, Systems/Structural
57. MTo Marital Therapy, other or unspecified orientation
58. NT Neurotherapy (low  intensity electrical stimulation o f  head)
59. OM Other Medications
60 OMai Angiotensin-converting enzyme inhibitor (enalapril)
61. OT Occupational Therapy
62. PI Sodium Pentothal interview
63. PM Psychotropic Medication
64. PMan Anti-anxiety
65. PMbb Beta blockers
66. PMda Dopamine agonist (bromocriptine)
67. PMde Antidepressant
68. PMdn Dopamine antagonist (tiapride)
69. PMga GABA agonist (acamprosate)
70. PMhy Hypnotic
71. PMli Lithium
72. PMna Narcotic antagonist (Naltrexone, nalmefene)
73. PMsa Serotonin antagonist (ritanserin)
74. PMsr Selective serotonin reuptake inhibitors (sertraline, fluoxetine, 
zimelidine)
75. PMsc Antipsychotic
76. PMst Stimulant
77. PMsv Psychedelic
78. PS Problem-Solving
79. PT Psychotherapy
80. PTin Insight-oriented
81. PTcl Client-centered, nondirective, supportive
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82. PTre Reality Therapy (Glasser)
83. RP Relapse Prevention (cognitive-behavioral skill training; if  not more
specifically codable)
84. RE REST Reduced Environmental Stimulation Therapy
(includes sensory deprivation + change messages)
85. RT Recreational Therapy
86. SH Self-Help Manual
87. SM Stress Management
88. SMde Systematic Desensitization
89. SMre Relaxation training only
90. SMsd Sensory deprivation (but not full REST)
91. SP Spiritual intervention
92. SPsc Spiritual counseling
93. SPsd Spiritual direction
94. SPip Intercessory prayer
95. SS Social Skills Training
96. SSas Assertiveness training
97. SSbr Behavior rehearsal
98. SSco Communication training
99. SScs Culturally sensitive social skills training
100. ST Standard Treatment, unspecified or minimally specified (Treatment
as usual) [If also received by EXP groups, specify them ST + . . .]
101. SV Surveillance
102. s x Sexual Counseling
103. TO Tobacco cessation treatment
104. TS Twelve-Step Facilitation
105. VS Videotape Self-Confrontation
106. Nurse Nurse intervention
107. TM Transcendental Meditation
More than one modality may be specified; e g., ED/SC/SM re/VS 
When including multiple modalities, list in alphabetical order 
CIRCLE what appears to be the primary treatment modality 
Additional codes may be added as new modalities are evaluated
CONTROL GROUP CODES (to be used instead o f  modality code)
LE
Assessment only Code as NT (Formerly AS) 
Legal sanctions only
MM Medical Monitoring only
NA N o pre-assessment or treatment
NT N o treatment, but assessed
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PL Placebo
PLat Attention identified as placebo (e.g. discussion)
including altered (sham) form o f  nonmedical treatment
PLom Oral medication
PLsu Sham surgery
PR Probation only
WL Waiting List
(Comparison treatment groups are specified by their modality codes)
TREATMENT SETTING CODES
AF Aftercare (outpatient)
DA Day Treatment
CL Classroom, educational
EA Employee Assistance Program
GP General Practitioner medical practice
HA Halfway House
IP Inpatient Hospital
IP Alcoholism/Drug special hospital or ward
IPgh General hospital - not special ward
IPps Psychiatric hospital - not special ward
JA Jail or Prison
MA Mail contact only
MS Mixed settings (e.g., inpatient phase plus outpatient phase; AA is not a
setting)
NO N o Treatment provided for alcohol problems (e.g., recruited for drug
study only)
OP Outpatient Alcohol Treatment
PH Telephone contact only
RE Residential Alcohol Treatment, not hospital
SH Self-Help (including AA, bibliotherapy)
UT Unspecified treatment setting
TREATMENT FORMAT CODES
CO Computer-administered
FA Family treatment (more than dyad)
GR Group treatment
IN Individual treatment
ENph Telephone contact only
MA Marital/couples treatment
MI Minimal therapist contact
Mlad Brief advice contact (not more than one session)
MIbi Bibliotherapy
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MX Mixed format (e.g., group plus individual)
NC N o treatment contact (e.g., by mail only; no treatment; assessment only)
SO Significant other treatment (without identified patient)
SOal Al-Anon group
SOin Individual SO treatment
SOgr Group SO treatment
US Unspecified treatment format
PRIMARY TREATMENT AGENT CODES
AC AJcohol/Drug Counselor (less than MA)
AP Acupuncturist
MA Master’s Level Counselor (other than Social Worker)
MD Physician, Psychiatrist
MX Mixed - treatment provided by varying levels o f  professionals
NA Not Applicable - no treatment agent
PA Paraprofessional or student trained especially for research 
project - not regular alcohol counselor
PC Pastoral Counselor, Clergy
PO Probation Officer
PS Psychologist
RN Nurse
sw Social Worker (MSW minimum)
TE Team
UN Unspecified treatment agent
TREATMENT GOAL CODES
AB Total Abstinence
CD Controlled/Moderate Drinking
HR General Harm Reduction; AB or CD not specified; include programs
working toward alcohol problem improvement without specifying goal (use for 
treatments with unspecified goal or client-selected goal)
NG No goal (use for untreated controls, etc.)
OT Primary treatment goal is other than modification o f  drinking 
(e.g., family therapy to improve family communication)
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Population Severity Rating:
4 = Severely Impaired Clinical Population (e.g ., alcoholics in treatment, with 
documented moderate to severe dependence)
3 = Problem Drinker Clinical Population (e  g ., drinkers seeking treatment because o f  
problems related to alcohol; available evidence does not indicate severe dependence
2 = Problem Drinker Nonclinical (e g ., drinkers with clear alcohol-related problems, but 
not seeking treatment; recruited for research only, not treatment; includes 
populations mandated into treatment where available evidence does not indicate 
severe problems or dependence, and populations identified via medical screening)
1 = Nonclinical (e.g., recruited for research only; available evidence indicated mild or no 
problems)
0 = Insufficient information to classify
Do not infer from setting alone (e  g., inpatient =  4)
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WEIGHTING SYSTEM  FOR TREATMENT EFFECTS
A main effect is reported at any FU point on alcohol consumption or alcohol 
problems measures, given appropriate statistical analysis. A  “matching” interaction 
effect in the absence o f  a main effect is not coded. Also, do not code for reported effect 
within a select subgroup o f  patients (e.g., smokers, older, nonabstainers) in the absence 
o f  an overall main effect.
Effects for Treatment A
+2 A>0
+2 AB>B
+1 A>B
+1 A>b
+ 1 A>a
+ 1 a_> B
-1 A=B
-1 A=a
-1 a<B
-1 C>A>B
-1 AB=B
-1 ABC=B
-1 A<AB
-2 A<B
-2 A<b
_2 AB<B
_2 A<0
A > no treatment, sham, placebo [also A=B>0; A>B=O]
Additive effect > treatment without A 
A > alternative treatment B without control 
A > brief, dissimilar treatment without control 
A > briefer form o f  same treatment without control 
a (brief A) better than or equal to from more extensive B without
control
A nsd from alternative treatment o f  comparable/greater intensity 
without control
A nsd from briefer form o f  same treatment without control 
a (minimal A) less effective than more extensive B without control 
Mixed differences among treatments without control
No additive effect above alternative treatment without control 
No additive effect o f  combination o f  modalities above alternative
treatment without control
A worse than alternative treatment B with A, without control 
A worse than alternative treatment B o f  comparable intensity,
without control
A not better than brief, dissimilar treatment
Outcome with B is worse when A  is added
A not better than no treatment, sham, placebo, or assessment only
"Control" above refers to a group not receiving treatment A or an alternative 
active treatment: no treatment, sham, or placebo
When a control group is present, the comparison o f  A with controls takes 
precedence over any other comparison in determination o f  the treatment effect 
classification
In a dismantling design (e.g., AB vs B vs NT), the specific component test (A B vs 
B) takes precedence over the combined effect (A B  vs NT) in judging the effect o f  
an additive component (A). Thus i f  AB=B>NT, A would be 0, B would be +2.
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In additive designs with multiple components, ABCD>B cannot be used to 
support individual components A, C, and D. However a lack o f  additive effect 
(ABCD=B) yields 0 scores for A, C, and D.
*A black asterisk may be used instead o f  a treatment effect code, if  in the 
reviewer's judgment the study is so flawed as to be uninterpretable (e.g., massive 
overall attrition; conclusion based on clearly improper statistical procedures). 
The justification for * rating must be specified.
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Megatable Project Rating Criteria
0-4 GROUP ALLOCATION 4 = Randomization
3 = Within-subjects counterbalanced design
2 = Case control, matching
1 = Quasi-experimental design, sequential cohorts
0 = Violated randomization or nonequivalent
groups
0-1 QUALITY CONTROL 1 = Treatment standardized by manual, procedures, 
specific training, etc.
0 = N o standardization specified
0-2 FOLLOW-UP RATE 
(at any follow-up 
point > 3mo)
2 = 85-100% follow-ups completed
1 -  70-84.9%  follow-ups completed
0 = <70% follow-ups completed, or follow-up less 
than 3 months
0-2 FOLLOW-UP LENGTH 2 = 1 2  months or longer
1 =6-11  months
0 = < 6 mo
0-1 CONTACT 1 = Personal or telephone contact for >70%  
o f  completed follow-ups
0 = Questionnaire, unspecified, or <70%
0-1 COLLATERALS 1 = Collaterals interviewed in >50% o f  cases
0 = N o collateral verification
0-1 OBJECTIVE 1 = Objective verification (records, serum, breath, 
neuropsychological)
0 = No objective verification
0-1 DROP-OUTS 1 = Treatment dropouts are included in at least 
some outcome data (e g., intent to treat 
analysis; compared on dv; mere statement o f  
the number o f  drop-outs does not count)
0 = Treatment dropouts not discussed or not 
accounted for (e g ., excluded noncompleters 
from all analyses)
0-1 ATTRITION 1 = Cases lost to follow-up are enumerated and
considered in outcome reporting (e.g ., counted 
as failures; compared with nonattrition cases on
prior characteristics)
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0 = Lost cases not enumerated or merely
enumerated, and not considered in any outcome 
reporting
0-1 INDEPENDENT
0-1 ANALYSES
0-1 MULTISITE
1 = FU done by treatment-blind interviewer 
0 = FU nonblind; not specified; questionnaire
1 = Appropriate statistical analyses o f  group 
differences are reported
0 = N o statistical analysis; inappropriate
1 = Parallel replications at 2 or more sites, with 
separate research teams
0 = Single site or comparisons o f  sites offering 
different programs
0-17 TOTAL
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Study:
Treatments
Modalities/Control Setting Format Agent Goal Tabled
A ____________________________ /________ /________ I________ I_______  ____
B _______________________________ /_________ /_________ /_________ /.________ ____
C _______________________________ /_________ /_________ /._________/.________ ____
D _______________________________ I_______ I_______ I_______ !______  ____
E _______________________________ /._________/._________I________ /_______  ____
F _________________________ /_______ I_______ i_______ /______  ___
Assignment: __Random
__Arbitrary/nonrandom (e g., alternating)
__Within-S counterbalanced
__Case-control or matching Matched on:____________________________
__Cohort
__Violated random
__Nonequivalent groups (do not code in megatable)
Stated diagnosis:______________________________________________________________
Characteristics o f  sample:_______% male Mean age:_______________________
Severity Classification:________  N o te s______________________________
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N  randomized/initiated into study sample:_______________(use as denominator for %
completed)
FU Intervals* ________  ________  ________  ________  ________  _______
N  completed ________  ________  ________  ________  ________  _______
% completed ________  ________  ________  ________ ________  ______
Outcome cod e________ ________  ________ ________  ________  ______
(A>B, etc.)*Follow-up interval is from intake/baseline, not from treatment termination
___  GROUP ALLOCATION 4 = Randomization
3 = Within-S counterbalanced
2 = Case control / matching
1 = Quasi-experimental design
0 = Violated randomization or nonequivalent groups
___  QUALITY CONTROL 1 = Treatment standardized by manual, specific 
training, etc.
0 = No standardization specified
___  FOLLOW-UP RATE
(at any follow-up 
point > 3mo)
2 = 85-100% follow-ups completed
1 = 70-84.9% follow-ups completed
0 = <70% follow-ups completed or FU less than 3 
months
___  FOLLOW-UP LENGTH 2 = 1 2  months or longer
1 =6-11 months
0 = < 6 mo
___  CONTACT 1 = Personal or telephone interview
0 = Questionnaire, unspecified
___  COLLATERALS 1 = Collaterals interviewed in >50% o f  cases
0 = No collateral verification in most cases
___  OBJECTIVE 1 = Objective verification (records, serum, breath, 
neuropsychological) in >50% o f  cases
0 = No objective verification in most cases
___  DROP-OUTS 1 = Treatment dropouts discussed and accounted for
0 = Treatment dropouts not discussed or accounted for
(e g., excluded all noncompleters)
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attrition
INDEPENDENT
ANALYSES
MULTISITE
1 = Cases lost to follow-up are discussed and included 
in analyses or outcome stats, etc
0 = Cases lost to follow-up are not discussed or 
excluded from analyses and outcome stats
1 = FU done by independent interviewer
0 = FU nonblind; not specified; questionnaire
1 = Acceptable statistical analyses o f  group differences 
0 = N o statistical analysis; inappropriate
1 =  Parallel replications at 2  or more sites
0 = Single site or comparison o f  sites offering different 
treatments
_____  TOTAL FINAL SCORES
MODALITY
x _____ TREATMENT EFFECT CODE (-2 to +2) = ____________________
x _____ TREATMENT EFFECT CODE (-2 to +2) = ____________________
x _____ TREATMENT EFFECT CODE (-2 to +2) = ____________________
x _____ TREATMENT EFFECT CODE (-2 to +2) = ____________________
Notes
Appendix B: All New Codings, Including All Disagreements for Inter-Rater Reliability
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